ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1,3,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
1,4,Stupor,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2,1,Hypercholesterolaemia,Elevated cholesterol,Lipid metabolism disorders,Metab,N
2,2,Lip dry,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
3,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
3,2,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
3,3,Mitochondrial cytopathy,Cell metabolism disorders NEC,Metabolism disorders NEC,Metab,N
4,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4,2,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,Y
4,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
4,4,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
4,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
5,1,Coronary artery thrombosis,Coronary artery disorders NEC,Coronary artery disorders,Card,Y
6,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
6,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
6,3,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
6,4,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
6,5,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
7,1,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
8,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
9,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
9,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
9,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
9,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
9,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
9,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
9,7,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
9,8,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
9,9,Headache,Headaches NEC,Headaches,Nerv,N
9,10,Myalgia,Muscle pains,Muscle disorders,Musc,N
9,11,Phobia,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
9,12,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
9,13,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
9,14,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
9,15,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
10,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
10,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
10,3,Headache,Headaches NEC,Headaches,Nerv,N
10,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
10,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
10,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
10,7,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
11,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
11,3,Semen analysis abnormal,Fertility analyses and other reproductive function procedures,Reproductive organ and breast investigations (excl hormone analyses),Inv,N
12,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
13,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
13,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
13,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
14,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
15,1,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
16,1,Hyperlipidaemia,Hyperlipidaemias NEC,Lipid metabolism disorders,Metab,N
17,1,Hyperlipidaemia,Hyperlipidaemias NEC,Lipid metabolism disorders,Metab,N
18,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
18,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
18,3,Semen analysis abnormal,Fertility analyses and other reproductive function procedures,Reproductive organ and breast investigations (excl hormone analyses),Inv,N
19,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
19,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
19,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
20,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
21,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
21,2,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
22,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
22,2,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
22,3,Neurosis,Anxiety disorders NEC,Anxiety disorders and symptoms,Psych,N
23,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
23,2,Blood lactate dehydrogenase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
23,3,Blood lactate dehydrogenase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
23,4,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
23,5,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
24,1,Hypertriglyceridaemia,Elevated triglycerides,Lipid metabolism disorders,Metab,N
25,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
25,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
26,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
26,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
26,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
27,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
28,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
28,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
29,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
29,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
29,3,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
29,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
29,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
30,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
30,2,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
30,3,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
31,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
32,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
33,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
34,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
35,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
35,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
35,3,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
36,1,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
36,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
36,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
36,4,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
36,5,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
36,6,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
36,7,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
36,8,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
36,9,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
36,10,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
36,11,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
37,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
37,2,Anosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
38,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
38,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
38,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
38,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
38,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
38,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
38,7,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
38,8,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
39,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
39,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
39,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
39,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
39,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
39,6,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
40,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
41,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
42,1,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
43,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
43,2,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
44,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
45,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
46,1,Ingrowing nail,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
47,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
48,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
49,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
50,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
50,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
50,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
51,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
51,2,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
51,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
52,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
53,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
54,1,Prothrombin time abnormal,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
54,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
54,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
55,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
56,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
57,1,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,Y
58,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
58,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
59,1,Paronychia,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
60,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
60,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
60,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
61,1,Blindness transient,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
61,2,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
62,1,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
63,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
64,1,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
64,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
65,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
66,1,Atrioventricular block second degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
67,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
68,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
69,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
69,2,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
69,3,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
70,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
71,1,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
72,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
72,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
72,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
73,1,Vasculitic rash,Skin vasculitides,Skin vascular abnormalities,Skin,N
74,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
75,1,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
76,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
76,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
76,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
77,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
77,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
77,3,Parotid gland enlargement,Salivary gland enlargements,Salivary gland conditions,Gastr,N
77,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
78,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
78,2,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
78,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
79,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
80,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
80,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
80,3,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
81,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
81,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
82,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
82,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
83,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
83,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
84,1,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
85,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
85,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
85,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
86,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
86,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
86,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
86,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
86,5,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
87,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
87,2,Headache,Headaches NEC,Headaches,Nerv,N
87,3,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
87,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
87,5,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
87,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
87,7,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
87,8,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
87,9,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
87,10,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
88,1,Hyperlipidaemia,Hyperlipidaemias NEC,Lipid metabolism disorders,Metab,N
89,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
89,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
90,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
90,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
91,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
92,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
93,1,Hepatitis A,Hepatitis virus infections,Viral infectious disorders,Infec,N
94,1,Hyperlipidaemia,Hyperlipidaemias NEC,Lipid metabolism disorders,Metab,N
95,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
95,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
95,3,Renal colic,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
96,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
96,2,Galactorrhoea,Lactation disorders,Breast disorders,Repro,N
97,1,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
98,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
99,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
100,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
100,2,Biliary dilatation,Structural and other bile duct disorders,Bile duct disorders,Hepat,N
100,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
100,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
101,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
101,2,Lipid metabolism disorder,Lipid metabolism and deposit disorders NEC,Lipid metabolism disorders,Metab,N
101,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
102,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
102,2,Retinitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
103,1,Lipoatrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
104,1,Hypercholesterolaemia,Elevated cholesterol,Lipid metabolism disorders,Metab,N
104,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
104,3,Hypertriglyceridaemia,Elevated triglycerides,Lipid metabolism disorders,Metab,N
105,1,Hyperlipidaemia,Hyperlipidaemias NEC,Lipid metabolism disorders,Metab,N
105,2,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,Y
106,1,Congenital acrochordon,Skin and subcutaneous tissue disorders congenital NEC,Skin and subcutaneous tissue disorders congenital,Cong,N
107,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
108,1,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
108,2,Hyperlipidaemia,Hyperlipidaemias NEC,Lipid metabolism disorders,Metab,N
109,1,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
110,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
110,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
110,3,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
110,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
111,1,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
112,1,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
113,1,Congenital acrochordon,Skin and subcutaneous tissue disorders congenital NEC,Skin and subcutaneous tissue disorders congenital,Cong,N
114,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
114,2,Retinitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
115,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
116,1,Corneal deposits,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
117,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
118,1,Myopathy,Myopathies,Muscle disorders,Musc,N
119,1,Hyperlipidaemia,Hyperlipidaemias NEC,Lipid metabolism disorders,Metab,N
120,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
120,2,Fat redistribution,Lipid metabolism and deposit disorders NEC,Lipid metabolism disorders,Metab,N
120,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
121,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
122,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
123,1,Deafness,Hearing losses,Hearing disorders,Ear,N
123,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
124,1,Fat tissue increased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
124,2,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
125,1,Blood osmolarity increased,Water and electrolyte analyses NEC,"Water, electrolyte and mineral investigations",Inv,N
125,2,Glucose tolerance decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
126,1,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
126,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
127,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
128,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
128,2,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
128,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
128,4,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
128,5,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
129,1,ACTH stimulation test abnormal,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
129,2,Cortisol decreased,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
129,3,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
129,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
129,5,Secondary adrenocortical insufficiency,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
130,1,Hypertriglyceridaemia,Elevated triglycerides,Lipid metabolism disorders,Metab,N
130,2,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
131,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
131,2,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
132,1,Arthritis reactive,Spondyloarthropathies,Joint disorders,Musc,N
132,2,Tenosynovitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
133,1,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
133,2,Obesity,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
134,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
134,2,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
134,3,Lipoatrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
134,4,Lipomatosis,Lipid metabolism and deposit disorders NEC,Lipid metabolism disorders,Metab,N
135,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
135,2,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
136,1,Deafness,Hearing losses,Hearing disorders,Ear,N
136,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
137,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
137,2,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
138,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
138,2,Hyperlipidaemia,Hyperlipidaemias NEC,Lipid metabolism disorders,Metab,N
138,3,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
138,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
139,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
139,2,Epididymal cyst,Testicular and epididymal neoplasms,Testicular and epididymal disorders,Repro,N
139,3,Hyperlipidaemia,Hyperlipidaemias NEC,Lipid metabolism disorders,Metab,N
139,4,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
140,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
141,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
141,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
141,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
141,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
142,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
143,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
144,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
144,2,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
144,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
145,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
146,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
146,2,Haemorrhagic diathesis,Bleeding tendencies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
147,1,Hyperlipidaemia,Hyperlipidaemias NEC,Lipid metabolism disorders,Metab,N
148,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
149,1,Fat redistribution,Lipid metabolism and deposit disorders NEC,Lipid metabolism disorders,Metab,N
149,2,Fat tissue increased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
149,3,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
150,1,Hyperlipidaemia,Hyperlipidaemias NEC,Lipid metabolism disorders,Metab,N
150,2,Lipoatrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
151,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
152,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
152,2,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
153,1,Acquired immunodeficiency syndrome,Retroviral infections,Viral infectious disorders,Infec,N
153,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
153,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
153,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
153,5,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
153,6,Pneumocystis jirovecii infection,Pneumocystis infections,Fungal infectious disorders,Infec,N
153,7,Pneumonia bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,Y
153,8,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
154,1,Migraine,Migraine headaches,Headaches,Nerv,N
154,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
155,1,Lipoatrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
155,2,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
156,1,Breast enlargement,Breast disorders NEC,Breast disorders,Repro,N
156,2,Lipoatrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
156,3,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
157,1,Hypercholesterolaemia,Elevated cholesterol,Lipid metabolism disorders,Metab,N
157,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
158,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
158,2,Lipoatrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
158,3,Lipohypertrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
159,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
160,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
160,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
160,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
160,4,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
161,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
162,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
162,2,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
163,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
163,2,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
164,1,Pancreatic pseudocyst,Cystic pancreatic disorders,Exocrine pancreas conditions,Gastr,N
164,2,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
165,1,Agoraphobia,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
165,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
165,3,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
165,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
166,1,Lipids abnormal,Lipoprotein and lipid tests NEC,Lipid analyses,Inv,N
167,1,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
167,2,Fat tissue increased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
167,3,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
167,4,Lipoatrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
167,5,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
167,6,Lipohypertrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
168,1,Hypercholesterolaemia,Elevated cholesterol,Lipid metabolism disorders,Metab,N
168,2,Hypertriglyceridaemia,Elevated triglycerides,Lipid metabolism disorders,Metab,N
169,1,Lipids abnormal,Lipoprotein and lipid tests NEC,Lipid analyses,Inv,N
169,2,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
170,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
170,2,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
171,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
171,2,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
171,3,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
171,4,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,Y
172,1,Lipids abnormal,Lipoprotein and lipid tests NEC,Lipid analyses,Inv,N
172,2,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
173,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
173,2,Hypertriglyceridaemia,Elevated triglycerides,Lipid metabolism disorders,Metab,N
173,3,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
173,4,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
174,1,Fat tissue increased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
175,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
175,2,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
175,3,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
176,1,Hyperlipidaemia,Hyperlipidaemias NEC,Lipid metabolism disorders,Metab,N
177,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
178,1,Anal pruritus,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
179,1,Headache,Headaches NEC,Headaches,Nerv,N
179,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
179,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
180,1,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
181,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
181,2,Pancreatic pseudocyst,Cystic pancreatic disorders,Exocrine pancreas conditions,Gastr,N
182,1,Hepatocellular injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
182,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
182,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
183,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
183,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
183,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
184,1,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
184,2,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
184,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
185,1,Brain stem infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
186,1,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
186,2,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
186,3,Hyperlipidaemia,Hyperlipidaemias NEC,Lipid metabolism disorders,Metab,N
186,4,Pancreatic cyst,Cystic pancreatic disorders,Exocrine pancreas conditions,Gastr,N
186,5,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
187,1,Lipids increased,Lipoprotein and lipid tests NEC,Lipid analyses,Inv,N
188,1,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
189,1,Post procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
190,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
191,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
192,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
192,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
192,3,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
193,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
193,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
194,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
194,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
195,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
196,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
197,1,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
198,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
199,1,Type IIb hyperlipidaemia,Inborn errors of lipid metabolism,Metabolic and nutritional disorders congenital,Cong,N
199,2,Xanthoma,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
200,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
201,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
201,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
201,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
201,4,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
201,5,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
202,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,Y
202,2,Headache,Headaches NEC,Headaches,Nerv,N
202,3,Hostility,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
202,4,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
202,5,Lymphocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
202,6,Social avoidant behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
203,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
203,2,Coronary artery disease,Coronary artery disorders NEC,Coronary artery disorders,Card,Y
203,3,Lipids increased,Lipoprotein and lipid tests NEC,Lipid analyses,Inv,N
204,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
204,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
204,3,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
204,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
205,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
205,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
205,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
205,4,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
206,1,Acute psychosis,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
207,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
207,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
208,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
209,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
209,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
209,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
210,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
210,2,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
211,1,Fat tissue increased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
211,2,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
211,3,Lipohypertrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
212,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
213,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
213,2,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
213,3,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
213,4,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
214,1,Hyperlipidaemia,Hyperlipidaemias NEC,Lipid metabolism disorders,Metab,N
215,1,Myopathy,Myopathies,Muscle disorders,Musc,N
216,1,Talipes,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
217,1,Premature separation of placenta,Haemorrhagic complications of pregnancy,Maternal complications of pregnancy,Preg,N
217,2,Stillbirth,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
218,1,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
219,1,Paraesthesia mucosal,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
220,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
221,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
221,2,Erythema nodosum,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
222,1,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
223,1,Abortion missed,Abortions not specified as induced or spontaneous,Abortions and stillbirth,Preg,N
223,2,Anembryonic gestation,Abortion related conditions and complications,Abortions and stillbirth,Preg,N
224,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
224,2,Ocular icterus,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
225,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
225,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
226,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
226,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
226,3,Oesophageal varices haemorrhage,Gastric and oesophageal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
227,1,Congenital bladder anomaly,Bladder disorders congenital,Renal and urinary tract disorders congenital,Cong,N
227,2,Congenital hydronephrosis,Renal and urinary tract disorders congenital NEC,Renal and urinary tract disorders congenital,Cong,N
227,3,Congenital urethral anomaly,Renal and urinary tract disorders congenital NEC,Renal and urinary tract disorders congenital,Cong,N
228,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
228,2,Renal pain,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
229,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
229,2,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
229,3,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
230,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
231,1,Foetal cardiac disorder,Foetal complications NEC,Foetal complications,Preg,N
232,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
233,1,Cholecystitis acute,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
233,2,Hepatitis cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
233,3,Hypercholesterolaemia,Elevated cholesterol,Lipid metabolism disorders,Metab,N
234,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
234,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
234,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
234,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
234,5,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
234,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
235,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
235,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
236,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
237,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
238,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
238,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
238,3,Partial seizures,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
239,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
239,2,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
240,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
241,1,Pancreatitis necrotising,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,Y
242,1,Galactorrhoea,Lactation disorders,Breast disorders,Repro,N
243,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
243,2,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
244,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
245,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
245,2,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
246,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
246,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
246,3,Retinal haemorrhage,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
246,4,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
247,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
248,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
248,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
249,1,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
250,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
250,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
251,1,Ureteric obstruction,Ureteric disorders NEC,Ureteric disorders,Renal,N
251,2,Ureterolithiasis,Urinary tract lithiasis NEC,Urolithiases,Renal,N
252,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
252,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
252,3,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
252,4,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
252,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
253,1,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
254,1,Multiple fractures,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
255,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
256,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
256,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
257,1,Appendicitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
258,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
258,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
259,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
259,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
259,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
260,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
260,2,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
260,3,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
261,1,Acquired immunodeficiency syndrome,Retroviral infections,Viral infectious disorders,Infec,N
261,2,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
261,3,Cytomegalovirus chorioretinitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
261,4,Hypogonadism,Endocrine abnormalities of gonadal function NEC,Endocrine disorders of gonadal function,Endo,N
261,5,Lipoatrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
261,6,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
262,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
262,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
262,3,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
262,4,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
262,5,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
262,6,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
262,7,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
262,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
262,9,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
263,1,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
264,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
265,1,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
265,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
266,1,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
267,1,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
267,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
267,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
268,1,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
268,2,Renal colic,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
269,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
269,2,Blood bicarbonate abnormal,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
269,3,Blood creatine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
269,4,Blood phosphorus decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
269,5,Oliguria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
269,6,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
270,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
270,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
270,3,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
271,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
271,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
271,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
272,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
272,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
272,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
273,1,Fat redistribution,Lipid metabolism and deposit disorders NEC,Lipid metabolism disorders,Metab,N
274,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
274,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
274,3,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
274,4,Post herpetic neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
274,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
275,1,Acute respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
275,2,Crepitations,General signs and symptoms NEC,General system disorders NEC,Genrl,N
275,3,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
275,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
275,5,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
275,6,Mycobacterium kansasii infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
275,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
275,8,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
276,1,CD4 lymphocytes increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
276,2,Eosinophilic hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
276,3,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
276,4,Viral load decreased,Virus identification and serology,Microbiology and serology investigations,Inv,N
277,1,Hyperphosphatasaemia,Metabolic disorders NEC,Metabolism disorders NEC,Metab,N
278,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
279,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
280,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
281,1,Hirsutism,Hypertrichoses,Skin appendage conditions,Skin,N
281,2,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
282,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
283,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
283,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
283,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
284,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
284,2,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
284,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
284,4,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
285,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
285,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
286,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
287,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
288,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
289,1,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
289,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
289,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
289,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
289,5,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
290,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
290,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
290,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
290,4,Ocular icterus,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
290,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
291,1,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
291,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
291,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
292,1,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
292,2,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
292,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
293,1,CD4 lymphocytes decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
293,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
293,3,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
293,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
294,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
295,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
296,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
297,1,CD4 lymphocytes increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
297,2,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
297,3,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
297,4,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
297,5,Viral load decreased,Virus identification and serology,Microbiology and serology investigations,Inv,N
298,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
298,2,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
299,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
299,2,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
299,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
299,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
300,1,Delivery,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
300,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
300,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
301,1,Abortion induced,Induced abortions,Obstetric and gynaecological therapeutic procedures,Surg,N
302,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
302,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
302,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
302,4,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
303,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
304,1,Double outlet right ventricle,Great vessel disorders congenital,Cardiac and vascular disorders congenital,Cong,N
304,2,Stillbirth,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
304,3,Ventricular septal defect,Cardiac septal defects congenital,Cardiac and vascular disorders congenital,Cong,N
305,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
306,1,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
306,2,Congenital choroid plexus cyst,Cerebral disorders congenital,Neurological disorders congenital,Cong,N
306,3,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
307,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
307,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
307,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
307,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
308,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
309,1,Double outlet right ventricle,Great vessel disorders congenital,Cardiac and vascular disorders congenital,Cong,N
309,2,Stillbirth,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
309,3,Ventricular septal defect,Cardiac septal defects congenital,Cardiac and vascular disorders congenital,Cong,N
309,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
310,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
310,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
310,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
311,1,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
311,2,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
311,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
311,4,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
312,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
312,2,Oesophageal atresia,Oesophageal disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
312,3,Trisomy 18,Autosomal chromosomal abnormalities,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
312,4,Ventricular septal defect,Cardiac septal defects congenital,Cardiac and vascular disorders congenital,Cong,N
313,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
313,2,Stillbirth,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
314,1,Conduction disorder,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
314,2,Petit mal epilepsy,Absence seizures,Seizures (incl subtypes),Nerv,N
315,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
315,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
315,3,Blood antidiuretic hormone increased,Pituitary analyses posterior,Endocrine investigations (incl sex hormones),Inv,N
315,4,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
315,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
315,6,Myoglobin blood increased,Musculoskeletal and soft tissue tests NEC,Musculoskeletal and soft tissue investigations (excl enzyme tests),Inv,N
315,7,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
316,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
316,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
316,3,Blood antidiuretic hormone increased,Pituitary analyses posterior,Endocrine investigations (incl sex hormones),Inv,N
316,4,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
316,5,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
316,6,Myalgia,Muscle pains,Muscle disorders,Musc,N
316,7,Myoglobin blood increased,Musculoskeletal and soft tissue tests NEC,Musculoskeletal and soft tissue investigations (excl enzyme tests),Inv,N
316,8,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
316,9,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
317,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
317,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
317,3,Vulvovaginal discomfort,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
318,1,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
319,1,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
320,1,Hydronephrosis,Renal obstructive disorders,Renal disorders (excl nephropathies),Renal,N
321,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
321,2,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
321,3,Lymphoedema,Lymphoedemas,Lymphatic vessel disorders,Vasc,N
322,1,Multiple fractures,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
322,2,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
322,3,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
323,1,Hyperlactacidaemia,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
323,2,Monoparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
323,3,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
323,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
324,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
324,2,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
325,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
325,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
325,3,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
326,1,Congenital hydronephrosis,Renal and urinary tract disorders congenital NEC,Renal and urinary tract disorders congenital,Cong,N
326,2,Delivery,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
326,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
327,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
327,2,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
327,3,Lymphoedema,Lymphoedemas,Lymphatic vessel disorders,Vasc,N
328,1,Abortion induced,Induced abortions,Obstetric and gynaecological therapeutic procedures,Surg,N
329,1,Erythema nodosum,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
329,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
329,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
329,4,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
330,1,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
330,2,Personality change,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
331,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
331,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
331,3,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
331,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
332,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
332,2,Renal colic,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
333,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
333,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
334,1,Alpha 1 foetoprotein abnormal,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
334,2,Alpha 1 foetoprotein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
335,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
335,2,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
335,3,Placental infarction,Placental abnormalities (excl neoplasms),"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
335,4,Umbilical cord abnormality,Umbilical cord complications,Neonatal and perinatal conditions,Preg,N
336,1,Pre-eclampsia,Hypertension associated disorders of pregnancy,Maternal complications of pregnancy,Preg,N
337,1,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
338,1,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
338,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
338,3,Small for dates baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
339,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
339,2,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
339,3,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
340,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
341,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
342,1,Gastritis haemorrhagic,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
342,2,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
343,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
343,2,Gastrointestinal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
344,1,Precocious puberty,Endocrine abnormalities of puberty,Endocrine disorders of gonadal function,Endo,N
345,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
345,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
346,1,Hepatitis B virus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
347,1,Leukoencephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,Y
348,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
349,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
349,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
349,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
350,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
351,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
352,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
353,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
354,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
354,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
354,3,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
354,4,Partial seizures,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
355,1,Alpha 1 foetoprotein abnormal,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
355,2,Laboratory test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
356,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
356,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
357,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
357,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
358,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
358,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
359,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
359,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
360,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
360,2,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,N
361,1,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
362,1,Hypomania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
363,1,Acute psychosis,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
364,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
365,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
365,2,Abdominal hernia,Abdominal hernias NEC,Abdominal hernias and other abdominal wall conditions,Gastr,N
365,3,Cardiac murmur,Cardiac auscultatory investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
365,4,Congenital anomaly,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
365,5,Cryptorchism,Male reproductive tract disorders congenital,Reproductive tract and breast disorders congenital,Cong,N
366,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
366,2,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
366,3,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
366,4,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
366,5,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
367,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
367,2,Malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
368,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
368,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
369,1,Atrophy,Trophic disorders,Tissue disorders NEC,Genrl,N
370,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
370,2,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
370,3,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
371,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
371,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
371,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
372,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
373,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
374,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
374,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
375,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
376,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
376,2,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
377,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
378,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
378,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
378,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
379,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
380,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
381,1,Pulmonary valve stenosis,Pulmonary valvular disorders,Cardiac valve disorders,Card,N
382,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
383,1,Cerebellar syndrome,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
384,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
384,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
384,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
384,4,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
384,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
384,6,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
384,7,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
384,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
385,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
385,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
385,3,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
385,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
385,5,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
385,6,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
385,7,Myalgia,Muscle pains,Muscle disorders,Musc,N
385,8,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
385,9,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
385,10,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
385,11,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
385,12,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
385,13,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
386,1,Congenital aplastic anaemia,Anaemias congenital (excl haemoglobinopathies),Blood and lymphatic system disorders congenital,Cong,N
387,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
387,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
387,3,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
387,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
387,5,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
387,6,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
387,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
388,1,Congenital gastric anomaly,Gastric disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
388,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
388,3,Oesophageal atresia,Oesophageal disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
388,4,Trisomy 18,Autosomal chromosomal abnormalities,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
388,5,Ventricular septal defect,Cardiac septal defects congenital,Cardiac and vascular disorders congenital,Cong,N
389,1,Tendonitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
389,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
390,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
391,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
392,1,Alpha 1 foetoprotein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
393,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
394,1,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
394,2,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,Y
395,1,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
395,2,Congenital choroid plexus cyst,Cerebral disorders congenital,Neurological disorders congenital,Cong,N
395,3,Kidney malformation,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
395,4,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
396,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
396,2,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
396,3,Haemorrhagic diathesis,Bleeding tendencies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
397,1,Haemorrhagic diathesis,Bleeding tendencies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
398,1,Haemorrhagic diathesis,Bleeding tendencies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
399,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
399,2,Haemarthrosis,Arthropathies NEC,Joint disorders,Musc,N
399,3,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
399,4,Soft tissue haemorrhage,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
400,1,Haemarthrosis,Arthropathies NEC,Joint disorders,Musc,N
400,2,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
400,3,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
400,4,Soft tissue haemorrhage,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
401,1,Metastases to lymph nodes,Metastases to specified sites,Metastases,Neopl,N
401,2,Metastases to skin,Metastases to specified sites,Metastases,Neopl,N
401,3,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
402,1,Abortion induced,Induced abortions,Obstetric and gynaecological therapeutic procedures,Surg,N
403,1,Cardiac malposition,Cardiac malpositions congenital,Cardiac and vascular disorders congenital,Cong,Y
403,2,Congenital diaphragmatic anomaly,Diaphragmatic disorders congenital,Respiratory disorders congenital,Cong,N
403,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
403,4,Hepatic displacement,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
404,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
405,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
405,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
405,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
406,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
407,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
407,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
407,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
408,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
409,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
409,2,Lipohypertrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
409,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
410,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
410,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
410,3,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
410,4,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
411,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
411,2,Osteoporotic fracture,Fractures NEC,Fractures,Musc,N
412,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
413,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
413,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
413,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
413,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
413,5,Mental status changes,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
413,6,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
413,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
414,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
414,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
415,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
415,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
416,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
417,1,Death neonatal,Death and sudden death,Fatal outcomes,Genrl,Y
418,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
419,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
419,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
420,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
420,2,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
420,3,Placental infarction,Placental abnormalities (excl neoplasms),"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
420,4,Umbilical cord abnormality,Umbilical cord complications,Neonatal and perinatal conditions,Preg,N
421,1,Clinodactyly,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
421,2,Congenital hand malformation,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
422,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
422,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
422,3,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
422,4,Enterocolitis haemorrhagic,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
422,5,Escherichia bacteraemia,Escherichia infections,Bacterial infectious disorders,Infec,N
422,6,Oesophagitis haemorrhagic,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
422,7,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
422,8,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
423,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
424,1,Acute coronary syndrome,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
424,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
424,3,Coronary artery disease,Coronary artery disorders NEC,Coronary artery disorders,Card,N
424,4,Electrocardiogram ST segment elevation,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
424,5,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
425,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
425,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
426,1,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
426,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
427,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
428,1,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
429,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
430,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
430,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
431,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
431,2,Cerebellar ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
431,3,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
431,4,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
431,5,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
431,6,Encephalitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
431,7,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
431,8,HIV-associated neurocognitive disorder,Retroviral infections,Viral infectious disorders,Infec,N
431,9,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
431,10,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
431,11,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
432,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
433,1,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
434,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
434,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
434,3,Schistosomiasis,Trematode infections,Helminthic disorders,Infec,N
435,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
436,1,Acne,Acnes,Skin appendage conditions,Skin,N
436,2,Dermatitis acneiform,Acnes,Skin appendage conditions,Skin,N
436,3,Exfoliative rash,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
436,4,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
436,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
436,6,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
436,7,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
437,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
437,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
437,3,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
437,4,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
437,5,Rosacea,Rosaceas,Skin appendage conditions,Skin,N
438,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
438,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
439,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
439,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
440,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
440,2,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
441,1,Hepatitis acute,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
441,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
442,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
442,2,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
443,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
443,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
443,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
443,4,Thought blocking,Thinking disturbances,Disturbances in thinking and perception,Psych,N
444,1,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
444,2,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
445,1,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
446,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
446,2,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
446,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
446,4,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
446,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
446,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
446,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
447,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
447,2,Amniotic cavity infection,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
447,3,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
447,4,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
448,1,Cortisol abnormal,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
448,2,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
448,3,Foot fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
448,4,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
448,5,Rib fracture,Thoracic cage fractures and dislocations,Bone and joint injuries,Inj&P,N
449,1,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
449,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
449,3,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
449,4,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
449,5,Clumsiness,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
449,6,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
449,7,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
449,8,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
449,9,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
449,10,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
449,11,Muscle spasticity,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
449,12,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
449,13,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
449,14,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
450,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
450,2,Organ failure,General signs and symptoms NEC,General system disorders NEC,Genrl,N
450,3,Systemic mycosis,Fungal infections NEC,Fungal infectious disorders,Infec,Y
451,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
451,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
451,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
452,1,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,Y
453,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
454,1,Oral disorder,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
454,2,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
454,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
455,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
455,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
456,1,Neuroleptic malignant syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
457,1,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
457,2,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
458,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
458,2,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
458,3,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
458,4,Fat redistribution,Lipid metabolism and deposit disorders NEC,Lipid metabolism disorders,Metab,N
458,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
459,1,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
460,1,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
461,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
461,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
462,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
462,2,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
462,3,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
463,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
464,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
464,2,Intraventricular haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
464,3,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
465,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
466,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
466,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
467,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
467,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
468,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
468,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
469,1,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
470,1,Cortisol decreased,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
470,2,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
470,3,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
470,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
470,5,Skin striae,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
470,6,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
471,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
471,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
472,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
472,2,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
472,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
473,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
473,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
473,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
473,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
473,5,Effusion,General signs and symptoms NEC,General system disorders NEC,Genrl,N
473,6,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
473,7,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
473,8,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
473,9,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
473,10,Myalgia,Muscle pains,Muscle disorders,Musc,N
473,11,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
473,12,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
473,13,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
473,14,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
473,15,Red blood cell sedimentation rate increased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
473,16,Serum ferritin increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
473,17,Still's disease,Rheumatoid arthropathies,Joint disorders,Musc,N
473,18,Synovitis,Synovial disorders,Synovial and bursal disorders,Musc,N
473,19,Transaminases increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
474,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
474,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
474,3,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
474,4,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
474,5,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
474,6,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
474,7,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
474,8,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
474,9,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
474,10,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
474,11,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
474,12,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
474,13,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
474,14,Headache,Headaches NEC,Headaches,Nerv,N
474,15,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
474,16,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
474,17,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
474,18,Musculoskeletal chest pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
474,19,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
474,20,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
474,21,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
474,22,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
474,23,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
474,24,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
474,25,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
474,26,Sleep terror,Parasomnias,Sleep disorders and disturbances,Psych,N
474,27,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
474,28,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
474,29,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
474,30,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
475,1,Focal segmental glomerulosclerosis,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
475,2,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
475,3,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
476,1,Stillbirth,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
476,2,Umbilical cord vascular disorder,Umbilical cord complications,Neonatal and perinatal conditions,Preg,N
477,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
477,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
477,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
477,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
477,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
477,6,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
477,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
478,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
479,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
480,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
480,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
480,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
481,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
482,1,Aortic valve sclerosis,Aortic valvular disorders,Cardiac valve disorders,Card,N
482,2,Apnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
482,3,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
482,4,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
482,5,Cardiac murmur,Cardiac auscultatory investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
482,6,Complication of delivery,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
482,7,Congenital anomaly in offspring,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
482,8,Congenital heart valve disorder,Cardiac valve disorders congenital,Cardiac and vascular disorders congenital,Cong,N
482,9,Congenital pulmonary valve disorder,Cardiac valve disorders congenital,Cardiac and vascular disorders congenital,Cong,N
482,10,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
482,11,Large for dates baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
482,12,Maternal drugs affecting foetus,Foetal and neonatal conditions associated with product exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
482,13,Maternal exposure timing unspecified,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
482,14,Neonatal respiratory arrest,Neonatal hypoxic conditions,Neonatal respiratory disorders,Resp,N
482,15,Pulmonary valve sclerosis,Pulmonary valvular disorders,Cardiac valve disorders,Card,N
482,16,Sudden infant death syndrome,Death and sudden death,Fatal outcomes,Genrl,Y
482,17,Ventricular hypertrophy,Myocardial disorders NEC,Myocardial disorders,Card,N
483,1,Virologic failure,Infections NEC,Infections - pathogen unspecified,Infec,N
484,1,Cardiac malposition,Cardiac malpositions congenital,Cardiac and vascular disorders congenital,Cong,N
484,2,Congenital diaphragmatic anomaly,Diaphragmatic disorders congenital,Respiratory disorders congenital,Cong,N
484,3,Congenital hepatobiliary anomaly,Hepatobiliary abnormalities congenital,Hepatobiliary disorders congenital,Cong,N
484,4,Deformity thorax,Trunk deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
484,5,Diaphragmatic aplasia,Diaphragmatic disorders congenital,Respiratory disorders congenital,Cong,N
484,6,Exomphalos,Gastrointestinal tract disorders congenital NEC,Gastrointestinal tract disorders congenital,Cong,N
484,7,Hepatic displacement,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
484,8,Microcephaly,Musculoskeletal and connective tissue disorders of skull congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
485,1,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
485,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
485,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
485,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
485,5,Pleocytosis,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
486,1,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
487,1,Bradyphrenia,Thinking disturbances,Disturbances in thinking and perception,Psych,N
487,2,Headache,Headaches NEC,Headaches,Nerv,N
487,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
487,4,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
487,5,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
488,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
488,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
488,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
489,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
489,2,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
489,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
489,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
489,5,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
490,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
490,2,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
490,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
491,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
491,2,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
491,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
491,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
491,5,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
492,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
492,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
493,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
493,2,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
493,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
493,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
494,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
495,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
495,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
496,1,Alpha 1 foetoprotein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
496,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
496,3,Laboratory test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
497,1,Intestinal ischaemia,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
498,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
498,2,Headache,Headaches NEC,Headaches,Nerv,N
499,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
499,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
500,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
500,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
500,3,Gestational diabetes,Pregnancy complicated by maternal disorders,Maternal complications of pregnancy,Preg,N
500,4,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
500,5,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
501,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
501,2,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
502,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
502,2,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
503,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
503,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
503,3,Gestational diabetes,Pregnancy complicated by maternal disorders,Maternal complications of pregnancy,Preg,N
503,4,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
503,5,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
504,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
504,2,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
505,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
506,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
506,2,Renal colic,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
507,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
508,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
508,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
508,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
509,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
510,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
511,1,Anal atresia,Anorectal disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
511,2,Anencephaly,Cerebral disorders congenital,Neurological disorders congenital,Cong,N
511,3,Bladder agenesis,Bladder disorders congenital,Renal and urinary tract disorders congenital,Cong,N
511,4,Bladder agenesis,Bladder disorders congenital,Renal and urinary tract disorders congenital,Cong,N
511,5,Blood iron decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
511,6,Blood iron decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
511,7,Caudal regression syndrome,Musculoskeletal and connective tissue disorders of spine congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
511,8,Cloacal exstrophy,Reproductive tract disorders congenital NEC,Reproductive tract and breast disorders congenital,Cong,N
511,9,Congenital anomaly,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
511,10,Congenital ectopic bladder,Bladder disorders congenital,Renal and urinary tract disorders congenital,Cong,N
511,11,Congenital genital malformation,Reproductive tract disorders congenital NEC,Reproductive tract and breast disorders congenital,Cong,N
511,12,Congenital musculoskeletal disorder,Musculoskeletal disorders congenital NEC,Musculoskeletal and connective tissue disorders congenital,Cong,N
511,13,Congenital musculoskeletal disorder of spine,Musculoskeletal and connective tissue disorders of spine congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
511,14,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
511,15,Exomphalos,Gastrointestinal tract disorders congenital NEC,Gastrointestinal tract disorders congenital,Cong,N
511,16,Exomphalos,Gastrointestinal tract disorders congenital NEC,Gastrointestinal tract disorders congenital,Cong,N
511,17,Exomphalos,Gastrointestinal tract disorders congenital NEC,Gastrointestinal tract disorders congenital,Cong,N
511,18,Fibrosis,Fibrosis NEC,Tissue disorders NEC,Genrl,N
511,19,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
511,20,Gastrointestinal disorder congenital,Gastrointestinal tract disorders congenital NEC,Gastrointestinal tract disorders congenital,Cong,N
511,21,Gastrointestinal disorder congenital,Gastrointestinal tract disorders congenital NEC,Gastrointestinal tract disorders congenital,Cong,N
511,22,Gastrointestinal malformation,Gastrointestinal tract disorders congenital NEC,Gastrointestinal tract disorders congenital,Cong,N
511,23,Genitalia external ambiguous,Reproductive tract disorders congenital NEC,Reproductive tract and breast disorders congenital,Cong,N
511,24,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
511,25,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
511,26,Meconium stain,Amniotic fluid and cavity disorders of pregnancy NEC,"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
511,27,Meningomyelocele,Central nervous system disorders congenital NEC,Neurological disorders congenital,Cong,N
511,28,Meningomyelocele,Central nervous system disorders congenital NEC,Neurological disorders congenital,Cong,N
511,29,Musculoskeletal deformity,Extremity deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
511,30,Musculoskeletal discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
511,31,Neural tube defect,Central nervous system disorders congenital NEC,Neurological disorders congenital,Cong,N
511,32,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
511,33,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
511,34,Sepsis neonatal,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
511,35,Spina bifida,Central nervous system disorders congenital NEC,Neurological disorders congenital,Cong,N
511,36,Tethered cord syndrome,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
511,37,Umbilical cord abnormality,Umbilical cord complications,Neonatal and perinatal conditions,Preg,N
511,38,Umbilical cord abnormality,Umbilical cord complications,Neonatal and perinatal conditions,Preg,N
512,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
512,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
512,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
512,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
513,1,Tendonitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
514,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
514,2,Lipoatrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
515,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
516,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
517,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
517,2,Gastrointestinal inflammation,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
517,3,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
517,4,Mycobacterium avium complex infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
518,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
518,2,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
519,1,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
519,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
520,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
520,2,Oromandibular dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
520,3,Systemic scleroderma,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
521,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
522,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
522,2,Hyperlipidaemia,Hyperlipidaemias NEC,Lipid metabolism disorders,Metab,N
522,3,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
522,4,Type 2 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
523,1,Cardiac ventricular thrombosis,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
523,2,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
523,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
524,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
525,1,Electrocardiogram T wave inversion,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
526,1,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
527,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
528,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
528,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
528,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
529,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
529,2,Headache,Headaches NEC,Headaches,Nerv,N
529,3,Malignant hypertension,Accelerated and malignant hypertension,Vascular hypertensive disorders,Vasc,N
530,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
530,2,Malignant hypertension,Accelerated and malignant hypertension,Vascular hypertensive disorders,Vasc,N
531,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
531,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
531,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
532,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
532,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
532,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
532,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
532,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
532,6,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
532,7,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
532,8,Myalgia,Muscle pains,Muscle disorders,Musc,N
532,9,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
532,10,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
532,11,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
532,12,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
532,13,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
532,14,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
533,1,Ocular icterus,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
534,1,CD4 lymphocytes decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
534,2,Hypothalamo-pituitary disorder,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
534,3,Secondary adrenocortical insufficiency,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
535,1,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
535,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
536,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
536,2,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
536,3,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
537,1,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
538,1,Central nervous system viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
538,2,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
539,1,Central nervous system viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
539,2,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
540,1,Hepatitis acute,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
541,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
541,2,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
541,3,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
541,4,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
542,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
542,2,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
542,3,Nodular regenerative hyperplasia,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
542,4,Oesophageal varices haemorrhage,Gastric and oesophageal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
542,5,Portal hypertension,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
542,6,Varices oesophageal,Oesophageal varices,Gastrointestinal vascular conditions,Gastr,N
543,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
543,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
543,3,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
543,4,Maternal exposure before pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
543,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
544,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
545,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
545,2,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
545,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
546,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
546,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
546,3,Product formulation issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
546,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
547,1,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
547,2,Ejaculation delayed,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
548,1,Intestinal malrotation,Intestinal disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
549,1,Coarctation of the aorta,Great vessel disorders congenital,Cardiac and vascular disorders congenital,Cong,N
550,1,Hyperparathyroidism,Hyperparathyroid disorders,Parathyroid gland disorders,Endo,N
550,2,Synovitis,Synovial disorders,Synovial and bursal disorders,Musc,N
551,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
551,2,Terminal state,General signs and symptoms NEC,General system disorders NEC,Genrl,N
552,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
552,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
553,1,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
553,2,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
554,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
554,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
555,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
555,2,Meralgia paraesthetica,Mononeuropathies,Peripheral neuropathies,Nerv,N
555,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
556,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
556,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
556,3,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
557,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
557,2,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
557,3,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
558,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
558,2,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
559,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
559,2,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
559,3,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
560,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
560,2,Hyperbilirubinaemia neonatal,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
561,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
561,2,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
562,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
563,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
563,2,Glucose urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
563,3,Protein urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
563,4,Renal tubular dysfunction,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
564,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
564,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
564,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
565,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
566,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
566,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
566,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
566,4,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
567,1,Electrocardiogram T wave amplitude decreased,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
568,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
568,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
569,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
569,2,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
569,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
569,4,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
569,5,Mycobacterium avium complex infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
569,6,Necrosis,Necrosis NEC,Tissue disorders NEC,Genrl,N
569,7,Parotid gland enlargement,Salivary gland enlargements,Salivary gland conditions,Gastr,N
569,8,Parotitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
569,9,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
570,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,Y
570,2,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
571,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
572,1,Pulmonary tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
573,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
573,2,Talipes,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
574,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
574,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
574,3,Ureteric obstruction,Ureteric disorders NEC,Ureteric disorders,Renal,N
575,1,Central nervous system inflammation,Central nervous system inflammatory disorders NEC,Central nervous system infections and inflammations,Nerv,N
575,2,Cerebellar ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
575,3,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
575,4,Encephalitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
575,5,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
575,6,HIV-associated neurocognitive disorder,Retroviral infections,Viral infectious disorders,Infec,N
575,7,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
575,8,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
575,9,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
576,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
576,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
577,1,Affect lability,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
577,2,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
577,3,Anal incontinence,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
577,4,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
577,5,Blood HIV RNA increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
577,6,CSF protein increased,Cerebrospinal fluid tests (excl microbiology),"Neurological, special senses and psychiatric investigations",Inv,N
577,7,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
577,8,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
577,9,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
577,10,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
577,11,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
577,12,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
577,13,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
577,14,HIV-associated neurocognitive disorder,Retroviral infections,Viral infectious disorders,Infec,N
577,15,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
577,16,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
577,17,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
577,18,Tardive dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
577,19,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
578,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
578,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
578,3,Macrocytosis,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
578,4,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
578,5,Premature rupture of membranes,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
579,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
579,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
579,3,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
580,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
580,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
580,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
580,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
580,5,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
581,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
581,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
582,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
582,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
582,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
583,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
583,2,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
584,1,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
585,1,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
585,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
585,3,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
586,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
586,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
586,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
587,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
587,2,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
588,1,Metastatic neoplasm,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
588,2,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
589,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
590,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
590,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
590,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
591,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
591,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
591,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
592,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
592,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
593,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
593,2,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
593,3,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
593,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
593,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
594,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
594,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
594,3,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
594,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
595,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
595,2,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
595,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
595,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
595,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
595,6,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
596,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
596,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
596,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
597,1,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
598,1,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
599,1,Ocular icterus,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
599,2,Underweight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
600,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
601,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
602,1,ACTH stimulation test abnormal,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
602,2,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
602,3,Blood corticotrophin decreased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
602,4,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
602,5,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
602,6,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
602,7,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
603,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
604,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
605,1,Ocular icterus,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
606,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
606,2,Yellow skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
607,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
608,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
609,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
609,2,Headache,Headaches NEC,Headaches,Nerv,N
609,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
610,1,Bronchial obstruction,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
610,2,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
610,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
610,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
610,5,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
610,6,Pulmonary tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
610,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
611,1,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
612,1,HIV infection,Retroviral infections,Viral infectious disorders,Infec,N
612,2,Refusal of treatment by patient,Social issues NEC,Lifestyle issues,SocCi,N
612,3,Regurgitation,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
613,1,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
614,1,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
615,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
616,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
617,1,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
617,2,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
618,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
618,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
618,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
618,4,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
618,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
619,1,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
619,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
619,3,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
620,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
621,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
621,2,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
621,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
622,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
622,2,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
622,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
622,4,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
622,5,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
622,6,Immunosuppressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
622,7,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
622,8,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
622,9,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
622,10,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
622,11,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
623,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
624,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
625,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
625,2,Pregnancy with implant contraceptive,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
626,1,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
626,2,Intensive care,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
627,1,Blood HIV RNA increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
627,2,CD4 lymphocytes decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
627,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
628,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
629,1,Mitochondrial toxicity,Cell metabolism disorders NEC,Metabolism disorders NEC,Metab,N
630,1,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
631,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
632,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
632,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
632,3,Ischaemia,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
632,4,Troponin I increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
633,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
633,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
633,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
633,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
633,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
634,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
634,2,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
634,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
634,4,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
634,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
634,6,Joint noise,Joint related signs and symptoms,Joint disorders,Musc,N
634,7,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
635,1,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
635,2,Ocular icterus,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
636,1,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
637,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
637,2,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
637,3,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
637,4,Pulmonary mass,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
637,5,Renal cancer metastatic,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
637,6,Renal mass,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
637,7,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
638,1,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
638,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
639,1,Hyperprolactinaemia,Anterior pituitary hyperfunction,Hypothalamus and pituitary gland disorders,Endo,N
640,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
640,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
641,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
641,2,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
642,1,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
642,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
642,3,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
643,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
643,2,Erythema nodosum,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
643,3,Polyarthritis,Arthropathies NEC,Joint disorders,Musc,N
644,1,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
644,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
645,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
645,2,Immature respiratory system,Newborn respiratory disorders NEC,Neonatal respiratory disorders,Resp,N
646,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
646,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
647,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
647,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
648,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
649,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
650,1,Addison's disease,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
650,2,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
650,3,Cortisol decreased,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
650,4,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
650,5,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
650,6,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
650,7,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
650,8,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
650,9,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
650,10,Skin striae,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
650,11,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
651,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
651,2,Volvulus,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
652,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
653,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
654,1,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
654,2,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
654,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
654,4,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
654,5,Sinus tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
655,1,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
656,1,Systemic scleroderma,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
657,1,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
658,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
659,1,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
659,2,Mononeuropathy multiplex,Mononeuropathies,Peripheral neuropathies,Nerv,N
660,1,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
660,2,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
660,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
660,4,Osteoporotic fracture,Fractures NEC,Fractures,Musc,N
661,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
661,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
661,3,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
662,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
662,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
662,3,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
663,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
663,2,Renal dysplasia,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
664,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
665,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
666,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
667,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
667,2,Immunosuppressant drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
667,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
668,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
668,2,Immunosuppressant drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
668,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
668,4,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
669,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
670,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
670,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
670,3,Generalised oedema,Oedema NEC,General system disorders NEC,Genrl,N
670,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
671,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
671,2,Immunosuppressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
672,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
672,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
672,3,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
672,4,Coronary artery disease,Coronary artery disorders NEC,Coronary artery disorders,Card,N
672,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
672,6,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
672,7,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
672,8,HIV associated nephropathy,Retroviral infections,Viral infectious disorders,Infec,N
672,9,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
672,10,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
672,11,Induration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
672,12,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
672,13,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
672,14,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
672,15,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
672,16,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
672,17,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
672,18,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
672,19,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
672,20,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
672,21,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
673,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
673,2,Lipids increased,Lipoprotein and lipid tests NEC,Lipid analyses,Inv,N
673,3,Migraine,Migraine headaches,Headaches,Nerv,N
673,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
673,5,Secondary hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
674,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
675,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
675,2,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
675,3,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
675,4,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
676,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
676,2,Urine abnormality,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
677,1,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
678,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
678,2,Maculopathy,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
679,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
679,2,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
679,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
679,4,Haemophilic arthropathy,Arthropathies NEC,Joint disorders,Musc,N
679,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
680,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
680,2,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
680,3,Pre-eclampsia,Hypertension associated disorders of pregnancy,Maternal complications of pregnancy,Preg,N
680,4,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
680,5,Twin pregnancy,Multiple pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
681,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
681,2,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
681,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
681,4,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
682,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,Y
683,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
683,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
683,3,Headache,Headaches NEC,Headaches,Nerv,N
683,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
683,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
683,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
683,7,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
683,8,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
684,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
684,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
685,1,Dyslipidaemia,Lipid metabolism and deposit disorders NEC,Lipid metabolism disorders,Metab,N
685,2,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
686,1,Bladder disorder,Bladder disorders NEC,Bladder and bladder neck disorders (excl calculi),Renal,N
686,2,Congenital cystic kidney disease,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
686,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
686,4,Vesicoureteric reflux,Bladder reflux conditions,Bladder and bladder neck disorders (excl calculi),Renal,N
687,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
687,2,Dyslipidaemia,Lipid metabolism and deposit disorders NEC,Lipid metabolism disorders,Metab,N
687,3,Lipids abnormal,Lipoprotein and lipid tests NEC,Lipid analyses,Inv,N
687,4,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
688,1,Acne,Acnes,Skin appendage conditions,Skin,N
688,2,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
688,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
688,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
688,5,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
688,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
689,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
689,2,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
690,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
691,1,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
691,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
691,3,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
692,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
692,2,Lymphocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
693,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
693,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
693,3,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
693,4,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
693,5,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
694,1,Congenital bladder anomaly,Bladder disorders congenital,Renal and urinary tract disorders congenital,Cong,N
694,2,Congenital cystic kidney disease,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
694,3,Congenital vesicoureteric reflux,Bladder disorders congenital,Renal and urinary tract disorders congenital,Cong,N
694,4,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
695,1,Foetal chromosome abnormality,Chromosomal abnormalities NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,Y
695,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
696,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
696,2,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
696,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
697,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
697,2,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
697,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
698,1,Dyslipidaemia,Lipid metabolism and deposit disorders NEC,Lipid metabolism disorders,Metab,N
698,2,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
699,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
700,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
701,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
701,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
701,3,Diabetic hyperosmolar coma,Coma states,Neurological disorders NEC,Nerv,N
701,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
701,5,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
701,6,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
701,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
701,8,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
701,9,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
701,10,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
701,11,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
701,12,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
702,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
702,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
702,3,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
702,4,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
702,5,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
702,6,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
702,7,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
703,1,Central obesity,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
703,2,Cortisol decreased,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
703,3,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
703,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
703,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
703,6,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
703,7,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
704,1,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
705,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
705,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
706,1,Alanine aminotransferase abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
706,2,Aspartate aminotransferase abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
706,3,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
706,4,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
706,5,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
706,6,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
707,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
707,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
707,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
707,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
707,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
708,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
709,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
709,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
709,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
710,1,Congenital anomaly,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
710,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
711,1,Congenital anomaly,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
711,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
712,1,Congenital anomaly,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
712,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
713,1,Congenital anomaly,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
713,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
714,1,Congenital anomaly,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
714,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
715,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
715,2,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
715,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
716,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
717,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
717,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
717,3,Cardiac failure,Heart failures NEC,Heart failures,Card,N
717,4,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
717,5,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
717,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
717,7,Hypotonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
717,8,Intraventricular haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
717,9,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
717,10,Necrosis,Necrosis NEC,Tissue disorders NEC,Genrl,N
717,11,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
717,12,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
717,13,Thymus hypoplasia,Immune system abnormalities congenital,Immune system disorders congenital,Cong,N
718,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
719,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
720,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
721,1,Encephalitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
721,2,Retroviral rebound syndrome,Retroviral infections,Viral infectious disorders,Infec,N
722,1,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
722,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
722,3,Fat tissue increased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
722,4,Hirsutism,Hypertrichoses,Skin appendage conditions,Skin,N
722,5,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
722,6,Hyperosmolar state,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
722,7,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
723,1,Blood uric acid increased,Metabolism tests NEC,"Metabolic, nutritional and blood gas investigations",Inv,N
723,2,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
724,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
725,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
725,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
726,1,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
726,2,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
727,1,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
727,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
728,1,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
728,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
729,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
729,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
729,3,Blood antidiuretic hormone increased,Pituitary analyses posterior,Endocrine investigations (incl sex hormones),Inv,N
729,4,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
729,5,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
729,6,Muscle injury,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
729,7,Myalgia,Muscle pains,Muscle disorders,Musc,N
729,8,Myoglobin blood increased,Musculoskeletal and soft tissue tests NEC,Musculoskeletal and soft tissue investigations (excl enzyme tests),Inv,N
729,9,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
729,10,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
730,1,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
730,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
730,3,Product label issue,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
730,4,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
730,5,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
730,6,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
731,1,Abortion induced,Induced abortions,Obstetric and gynaecological therapeutic procedures,Surg,Y
731,2,Congenital anomaly,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
732,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
732,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
733,1,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
733,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
733,3,Retrograde ejaculation,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
734,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
734,2,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
734,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
734,4,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
734,5,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
734,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
734,7,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
735,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
735,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
735,3,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
735,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
735,5,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
736,1,Immune reconstitution inflammatory syndrome associated tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
737,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
738,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
738,2,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
738,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
739,1,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
739,2,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
739,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
739,4,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
739,5,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
740,1,Immune reconstitution inflammatory syndrome associated tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
741,1,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
741,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
741,3,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
742,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
742,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
742,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
743,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
744,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
745,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
745,2,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
746,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
746,2,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
746,3,Fat tissue increased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
747,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
747,2,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
748,1,Atrioventricular block first degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
748,2,Electrocardiogram PR prolongation,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
748,3,Electrocardiogram T wave inversion,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
749,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
749,2,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
750,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
750,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
750,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
750,4,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
751,1,Motor neurone disease,Motor neurone diseases,Neuromuscular disorders,Nerv,N
751,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
751,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
752,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
753,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
754,1,Femur fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
754,2,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
755,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
755,2,Rosacea,Rosaceas,Skin appendage conditions,Skin,N
756,1,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
756,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
756,3,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
757,1,End stage renal disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
757,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
757,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
757,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
757,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
758,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
758,2,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
759,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
759,2,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
760,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
761,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
762,1,Campylobacter gastroenteritis,Campylobacter infections,Bacterial infectious disorders,Infec,N
762,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
763,1,Congenital melanocytic naevus,Skin and subcutaneous tissue disorders congenital NEC,Skin and subcutaneous tissue disorders congenital,Cong,N
764,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
765,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
766,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
767,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
767,2,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
768,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
769,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
769,2,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
770,1,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
770,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
771,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
771,2,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
772,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
773,1,Decreased eye contact,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
773,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
773,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
773,4,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
773,5,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
773,6,Slow speech,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
773,7,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
774,1,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
774,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
775,1,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
775,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
775,3,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
776,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
776,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
777,1,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
777,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
778,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
779,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
780,1,HIV infection,Retroviral infections,Viral infectious disorders,Infec,N
780,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
780,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
781,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
782,1,Blood HIV RNA increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
782,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
782,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
782,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
783,1,Congenital ureterocele,Ureteric disorders congenital,Renal and urinary tract disorders congenital,Cong,N
783,2,Foetal cystic hygroma,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
783,3,Kidney duplex,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
783,4,Umbilical cord abnormality,Umbilical cord complications,Neonatal and perinatal conditions,Preg,N
784,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
784,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
785,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
785,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
786,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
786,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
786,3,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
786,4,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
786,5,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
786,6,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
786,7,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
786,8,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
786,9,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
786,10,Myopathy,Myopathies,Muscle disorders,Musc,N
786,11,Oliguria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
786,12,Osteomalacia,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
786,13,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
786,14,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
787,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
788,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
789,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
789,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
790,1,Blood HIV RNA increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
790,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
790,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
791,1,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
791,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
792,1,Amniotic band syndrome,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
792,2,Congenital musculoskeletal disorder of limbs,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
792,3,Neonatal aspiration,Newborn respiratory disorders NEC,Neonatal respiratory disorders,Resp,N
792,4,Placental disorder,Placental abnormalities (excl neoplasms),"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
792,5,Stillbirth,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
792,6,Syndactyly,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
792,7,Talipes,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
793,1,Foetal distress syndrome,Foetal complications NEC,Foetal complications,Preg,N
793,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
794,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
794,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
795,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
795,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
796,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
796,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
796,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
797,1,Congenital teratoma,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
797,2,Conjunctival haemorrhage,Conjunctival and corneal bleeding and vascular disorders,Ocular haemorrhages and vascular disorders NEC,Eye,N
797,3,Cryptorchism,Male reproductive tract disorders congenital,Reproductive tract and breast disorders congenital,Cong,N
797,4,Facial paresis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
797,5,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
797,6,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
798,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
798,2,Hyperlipidaemia,Hyperlipidaemias NEC,Lipid metabolism disorders,Metab,N
798,3,Pancreatic cyst,Cystic pancreatic disorders,Exocrine pancreas conditions,Gastr,N
798,4,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
799,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
799,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
799,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
799,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
800,1,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
800,2,Poor peripheral circulation,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
801,1,Cortisol decreased,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
801,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
801,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
801,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
801,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
802,1,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
802,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
802,3,Rib fracture,Thoracic cage fractures and dislocations,Bone and joint injuries,Inj&P,N
803,1,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
803,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
803,3,Rib fracture,Thoracic cage fractures and dislocations,Bone and joint injuries,Inj&P,N
804,1,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
804,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
804,3,Rib fracture,Thoracic cage fractures and dislocations,Bone and joint injuries,Inj&P,N
805,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
806,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
806,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
806,3,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
806,4,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
806,5,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
807,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
808,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
809,1,Mitochondrial myopathy,Genetic mitochondrial abnormalities NEC,Cytoplasmic disorders congenital,Cong,N
810,1,Mitochondrial myopathy,Genetic mitochondrial abnormalities NEC,Cytoplasmic disorders congenital,Cong,N
811,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
812,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
813,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
814,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
815,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
816,1,Anaemia postoperative,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
817,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
817,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
818,1,Bell's palsy,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
819,1,Haemophilia,Coagulation disorders congenital,Blood and lymphatic system disorders congenital,Cong,Y
820,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
820,2,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
820,3,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
820,4,Varices oesophageal,Oesophageal varices,Gastrointestinal vascular conditions,Gastr,N
821,1,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
821,2,Pulmonary thrombosis,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
822,1,Pulmonary thrombosis,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
823,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
823,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
824,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
825,1,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
826,1,Foetal distress syndrome,Foetal complications NEC,Foetal complications,Preg,N
826,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
827,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
827,2,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
827,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
828,1,CD4 lymphocytes decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
828,2,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
828,3,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
828,4,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
828,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
828,6,Placental insufficiency,Placental abnormalities (excl neoplasms),"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
828,7,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
829,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
829,2,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
829,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
829,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
830,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
830,2,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
830,3,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
831,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
831,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
831,3,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
832,1,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
832,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
832,3,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
833,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
833,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
833,3,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
833,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
833,5,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
834,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
834,2,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
834,3,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
834,4,Pregnancy on contraceptive,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
835,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
836,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
836,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
836,3,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
837,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
837,2,Focal segmental glomerulosclerosis,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
837,3,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
837,4,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
837,5,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
838,1,Cerebral ventricle dilatation,Structural brain disorders NEC,Structural brain disorders,Nerv,N
838,2,Cerebral ventricle dilatation,Structural brain disorders NEC,Structural brain disorders,Nerv,N
838,3,Congenital musculoskeletal disorder of skull,Musculoskeletal and connective tissue disorders of skull congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
838,4,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
838,5,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
838,6,Spina bifida,Central nervous system disorders congenital NEC,Neurological disorders congenital,Cong,N
839,1,Abortion induced,Induced abortions,Obstetric and gynaecological therapeutic procedures,Surg,N
839,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
839,3,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
840,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
840,2,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
840,3,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
840,4,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
840,5,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
840,6,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
840,7,Premature rupture of membranes,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
840,8,Twin pregnancy,Multiple pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
840,9,Virologic failure,Infections NEC,Infections - pathogen unspecified,Infec,N
841,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
842,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
843,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
843,2,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
843,3,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
843,4,Metastatic neoplasm,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
843,5,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
843,6,Terminal state,General signs and symptoms NEC,General system disorders NEC,Genrl,N
843,7,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
844,1,HIV infection,Retroviral infections,Viral infectious disorders,Infec,N
844,2,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
844,3,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
844,4,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
844,5,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
845,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
845,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
845,3,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
846,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
846,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
847,1,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
847,2,Stillbirth,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
848,1,Brain malformation,Central nervous system disorders congenital NEC,Neurological disorders congenital,Cong,N
848,2,Congenital central nervous system anomaly,Central nervous system disorders congenital NEC,Neurological disorders congenital,Cong,N
848,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
848,4,Pulmonary hypoplasia,Pulmonary and bronchial disorders congenital,Respiratory disorders congenital,Cong,N
849,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
850,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
851,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
852,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
853,1,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
853,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
853,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
853,4,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
854,1,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
855,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
856,1,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
856,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
856,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
857,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
857,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
857,3,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
857,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
857,5,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
857,6,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
857,7,Right ventricular dilatation,Myocardial disorders NEC,Myocardial disorders,Card,N
858,1,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
858,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
858,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
859,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
859,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
859,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
859,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
859,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
860,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
860,2,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
860,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
860,4,Transaminases increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
861,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,Y
861,2,Oncologic complication,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
862,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
862,2,Personality change,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
863,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
864,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
865,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
865,2,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
865,3,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
865,4,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
865,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
865,6,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
865,7,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
865,8,Personality change,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
865,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
866,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
866,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
867,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
868,1,Foetal distress syndrome,Foetal complications NEC,Foetal complications,Preg,N
868,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
868,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
869,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
869,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
869,3,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
870,1,Foetal distress syndrome,Foetal complications NEC,Foetal complications,Preg,N
870,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
870,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
871,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
871,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
872,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
872,2,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
873,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
873,2,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
873,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
873,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
873,5,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
873,6,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
873,7,Personality change,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
873,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
874,1,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
875,1,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
875,2,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
875,3,Pseudo Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
876,1,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
876,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
876,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
876,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
876,5,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
876,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
876,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
876,8,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
876,9,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
877,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
878,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
878,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
879,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
880,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
880,2,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
880,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
880,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
881,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
882,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
883,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
883,2,Secondary adrenocortical insufficiency,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
884,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
885,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
886,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
887,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
888,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
888,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
888,3,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
888,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
888,5,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
889,1,Lipoma,Soft tissue neoplasms benign NEC,Soft tissue neoplasms benign,Neopl,N
890,1,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
890,2,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
890,3,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
890,4,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
890,5,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
891,1,Lipoma,Soft tissue neoplasms benign NEC,Soft tissue neoplasms benign,Neopl,N
892,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
892,2,Placenta praevia,Placental abnormalities (excl neoplasms),"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
893,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
893,2,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
893,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
893,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
894,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
895,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
896,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
896,2,Middle insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
897,1,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
898,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
898,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
898,3,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
899,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
899,2,Leishmaniasis,Leishmania infections,Protozoal infectious disorders,Infec,N
900,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
901,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
902,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
902,2,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
903,1,Blood electrolytes increased,Water and electrolyte analyses NEC,"Water, electrolyte and mineral investigations",Inv,N
903,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
904,1,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
904,2,Visual brightness,Visual disorders NEC,Vision disorders,Eye,N
904,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
905,1,Gestational diabetes,Pregnancy complicated by maternal disorders,Maternal complications of pregnancy,Preg,N
906,1,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
906,2,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
906,3,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
907,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
908,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
908,2,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
908,3,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
908,4,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
908,5,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
908,6,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
908,7,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
908,8,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
908,9,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
909,1,Blood HIV RNA,Virus identification and serology,Microbiology and serology investigations,Inv,N
909,2,Blood HIV RNA increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
909,3,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
909,4,Subcutaneous abscess,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
909,5,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
909,6,Viral mutation identified,Virus identification and serology,Microbiology and serology investigations,Inv,N
909,7,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
910,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
911,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
911,2,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
912,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
913,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
913,2,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
914,1,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
914,2,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
914,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
914,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
914,5,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
914,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
915,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
915,2,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
915,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
915,4,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
915,5,Lipohypertrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
915,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
915,7,Skin striae,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
915,8,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
916,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
916,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
916,3,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
917,1,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
917,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
918,1,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
918,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
919,1,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
919,2,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
919,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
920,1,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
920,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
921,1,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
921,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
922,1,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
922,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
923,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
923,2,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
923,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
924,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
925,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
926,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
927,1,Ammonia increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
927,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
927,3,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
928,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
928,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
929,1,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
930,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
931,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
932,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
933,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
933,2,Central pain syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
933,3,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
933,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
934,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
935,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
935,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
935,3,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
935,4,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
936,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
936,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
937,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
937,2,Hepatitis C RNA increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
937,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
937,4,Unintentional use for unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
938,1,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
939,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
940,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
941,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
942,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
943,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
943,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
943,3,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
944,1,Menstrual disorder,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
945,1,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
946,1,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
946,2,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
946,3,Pseudo Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
947,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
947,2,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
948,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
949,1,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
949,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
950,1,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
951,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
951,2,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
952,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
953,1,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
954,1,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
955,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
955,2,Body temperature abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
955,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
955,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
955,5,Migraine,Migraine headaches,Headaches,Nerv,N
955,6,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
955,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
955,8,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
955,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
955,10,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
956,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
957,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
958,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
959,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
960,1,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
960,2,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
961,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
962,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
963,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
963,2,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
963,3,Inflammatory bowel disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
963,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
964,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
965,1,Bipolar I disorder,Bipolar disorders,Manic and bipolar mood disorders and disturbances,Psych,N
965,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
965,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
965,4,Soliloquy,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
966,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
966,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
966,3,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
966,4,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
966,5,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
967,1,Fanconi syndrome,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
967,2,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
967,3,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
968,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
968,2,Petit mal epilepsy,Absence seizures,Seizures (incl subtypes),Nerv,N
968,3,Staring,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
968,4,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
969,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
969,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
969,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
969,4,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
970,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
970,2,Heart rate abnormal,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
970,3,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
971,1,Acute on chronic liver failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
971,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
971,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
971,4,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
971,5,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
971,6,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
971,7,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
971,8,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
971,9,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
971,10,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
971,11,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
971,12,Portal vein thrombosis,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
971,13,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
972,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
972,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
972,3,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
972,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
973,1,Epidermodysplasia verruciformis,Papilloma viral infections,Viral infectious disorders,Infec,N
973,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
974,1,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
975,1,Hepatitis cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
976,1,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
977,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
977,2,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
977,3,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
977,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
978,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
978,2,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
979,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
980,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
980,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
980,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
981,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
982,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
982,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
982,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
983,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
983,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
984,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
984,2,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
985,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
986,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
986,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
987,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
987,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
988,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
988,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
989,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
989,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
989,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
990,1,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
990,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
990,3,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
990,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
991,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
991,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
991,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
992,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
992,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
993,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
993,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
993,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
994,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
994,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
995,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
995,2,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
995,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
995,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
996,1,Road traffic accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
996,2,Upper limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
997,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
997,2,Glomerulonephritis,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
998,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
999,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
999,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1000,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1001,1,Hepatic haemorrhage,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
1001,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1002,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1002,2,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1002,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
1002,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1002,5,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1003,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
1004,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1004,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1004,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1004,4,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1005,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1005,2,Orchitis,Male reproductive tract infections,Infections - pathogen unspecified,Infec,N
1006,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1007,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1007,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1007,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1007,4,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1007,5,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1007,6,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1007,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1008,1,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1008,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1008,3,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1009,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1009,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1009,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1009,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1009,5,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1010,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1011,1,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1012,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1012,2,Haemoglobin abnormal,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1012,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1013,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
1013,2,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
1014,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1014,2,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
1014,3,Virologic failure,Infections NEC,Infections - pathogen unspecified,Infec,N
1015,1,Foot fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1015,2,Neuropsychological symptoms,Mental disorders due to a general medical condition NEC,Psychiatric disorders NEC,Psych,N
1016,1,Atrial flutter,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1016,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1016,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1016,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1016,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1016,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1016,7,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1017,1,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1017,2,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
1018,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1018,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1018,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1018,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1019,1,Motor neurone disease,Motor neurone diseases,Neuromuscular disorders,Nerv,N
1020,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1020,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1021,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1021,2,Scrotal swelling,Scrotal disorders NEC,Penile and scrotal disorders (excl infections and inflammations),Repro,N
1021,3,Seminoma,Testicular neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
1022,1,Affect lability,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
1022,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1022,3,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1022,4,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1022,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1022,6,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
1022,7,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
1022,8,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1023,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1023,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1024,1,Atrial flutter,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1024,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1024,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1024,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1024,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1024,6,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1024,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1024,8,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1025,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1025,2,Injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1026,1,Monoplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1027,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1028,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1029,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1029,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1029,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1030,1,Gastric varices haemorrhage,Gastric and oesophageal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
1031,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1031,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1031,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1031,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1032,1,Monoplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1033,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1034,1,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
1035,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1036,1,Urethritis noninfective,Urethral infections and inflammations,Urethral disorders (excl calculi),Renal,N
1037,1,Urethritis noninfective,Urethral infections and inflammations,Urethral disorders (excl calculi),Renal,N
1038,1,Blood HIV RNA increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
1038,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1038,3,Viral mutation identified,Virus identification and serology,Microbiology and serology investigations,Inv,N
1039,1,Blood HIV RNA increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
1039,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1040,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1041,1,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1042,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1042,2,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1042,3,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1042,4,Dizziness postural,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1042,5,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1042,6,Glycosuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1042,7,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1042,8,Myopathy,Myopathies,Muscle disorders,Musc,N
1042,9,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1042,10,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1043,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1043,2,Acne,Acnes,Skin appendage conditions,Skin,N
1043,3,Cortisol decreased,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
1043,4,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1043,5,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1043,6,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1043,7,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1044,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
1045,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
1046,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1046,2,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1046,3,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1046,4,Generalised anxiety disorder,Anxiety disorders NEC,Anxiety disorders and symptoms,Psych,N
1046,5,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1046,6,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
1046,7,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1046,8,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
1046,9,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1046,10,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1046,11,Social avoidant behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1047,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1048,1,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1048,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1048,3,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1049,1,Adrenocortical insufficiency acute,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1049,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1050,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
1050,2,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1050,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1051,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1051,2,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1051,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1052,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1052,2,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1052,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1053,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1053,2,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1053,3,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1054,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1054,2,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1054,3,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1055,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1055,2,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1055,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1056,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1056,2,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1056,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1057,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1057,2,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1057,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1058,1,Hypercholesterolaemia,Elevated cholesterol,Lipid metabolism disorders,Metab,N
1058,2,T-lymphocyte count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1059,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1060,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1060,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1061,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1062,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1062,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1063,1,Near death experience,Perception disturbances NEC,Disturbances in thinking and perception,Psych,N
1064,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1065,1,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1065,2,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1065,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1066,1,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1066,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1066,3,Hirsutism,Hypertrichoses,Skin appendage conditions,Skin,N
1066,4,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1066,5,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1067,1,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1067,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1067,3,Myopathy,Myopathies,Muscle disorders,Musc,N
1067,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1068,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1068,2,Generalised anxiety disorder,Anxiety disorders NEC,Anxiety disorders and symptoms,Psych,N
1068,3,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1068,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1068,5,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
1068,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1068,7,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1069,1,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
1069,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1069,3,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1070,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1071,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1071,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1071,3,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
1072,1,Acute coronary syndrome,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1072,2,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1072,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1072,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1072,5,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1073,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1074,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1074,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1075,1,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
1075,2,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1075,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1076,1,International normalised ratio abnormal,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
1076,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1077,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
1077,2,Pustule,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1077,3,Skin sensitisation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1078,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1078,2,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1079,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1079,2,Fibrosis,Fibrosis NEC,Tissue disorders NEC,Genrl,N
1079,3,Gallbladder polyp,Gallbladder disorders NEC,Gallbladder disorders,Hepat,N
1079,4,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
1079,5,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1079,6,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1079,7,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1080,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1080,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1080,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1080,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1080,5,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1081,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1081,2,Body fat disorder,Lipid metabolism and deposit disorders NEC,Lipid metabolism disorders,Metab,N
1081,3,Cortisol decreased,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
1081,4,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1081,5,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1081,6,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1081,7,Ecchymosis,Purpura and related conditions,Skin vascular abnormalities,Skin,N
1081,8,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1081,9,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1081,10,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1081,11,Hypothalamic pituitary adrenal axis suppression,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
1081,12,Increased tendency to bruise,Bleeding tendencies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1081,13,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1081,14,Lipohypertrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
1081,15,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1081,16,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1081,17,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
1082,1,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
1082,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1083,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1083,2,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1083,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1084,1,Cortisol decreased,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
1084,2,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1084,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1084,4,Oropharyngeal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
1084,5,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1084,6,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1085,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1086,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1087,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
1087,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1088,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
1088,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1089,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1089,2,Activated partial thromboplastin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
1089,3,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1089,4,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1089,5,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1089,6,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1089,7,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1089,8,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1089,9,Bilirubin conjugated increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1089,10,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1089,11,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1089,12,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1089,13,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1089,14,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1089,15,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1089,16,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1089,17,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1089,18,Headache,Headaches NEC,Headaches,Nerv,N
1089,19,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1089,20,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1089,21,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1089,22,Infusion site vesicles,Infusion site reactions,Administration site reactions,Genrl,N
1089,23,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1089,24,Liver tenderness,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
1089,25,Myalgia,Muscle pains,Muscle disorders,Musc,N
1089,26,Ocular icterus,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1089,27,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1089,28,Protein total increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1089,29,Prothrombin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
1089,30,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1089,31,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1089,32,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1089,33,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1089,34,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1090,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1091,1,Acute hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
1092,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1093,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1093,2,Secondary adrenocortical insufficiency,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
1094,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1095,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
1095,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1096,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1096,2,Secondary adrenocortical insufficiency,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
1097,1,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1097,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1098,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
1098,2,Central obesity,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1098,3,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1098,4,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1098,5,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1098,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1098,7,Glucocorticoids increased,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
1098,8,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1098,9,Skin striae,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
1098,10,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1099,1,Retinal toxicity,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
1100,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1100,2,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
1101,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1101,2,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
1101,3,Hepatocellular carcinoma,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
1102,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1102,2,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1102,3,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1103,1,Diverticular perforation,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,N
1104,1,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
1104,2,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1105,1,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1105,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1106,1,Fanconi syndrome acquired,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1106,2,Progressive external ophthalmoplegia,Genetic mitochondrial abnormalities NEC,Cytoplasmic disorders congenital,Cong,N
1107,1,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
1107,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1107,3,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
1108,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1108,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1109,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
1109,2,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1109,3,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1109,4,Behaviour disorder,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1109,5,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1109,6,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1109,7,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1109,8,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1109,9,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1109,10,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1109,11,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
1109,12,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1109,13,Ear discomfort,Ear disorders NEC,Aural disorders NEC,Ear,N
1109,14,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
1109,15,Eye movement disorder,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
1109,16,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1109,17,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
1109,18,Libido decreased,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
1109,19,Lipids increased,Lipoprotein and lipid tests NEC,Lipid analyses,Inv,N
1109,20,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1109,21,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1109,22,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1109,23,Myalgia,Muscle pains,Muscle disorders,Musc,N
1109,24,Nasal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1109,25,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1109,26,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1109,27,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1109,28,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1109,29,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
1109,30,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1109,31,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1109,32,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1109,33,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1109,34,Skin sensitisation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1109,35,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1109,36,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1110,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1111,1,Fanconi syndrome,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
1111,2,Progressive external ophthalmoplegia,Genetic mitochondrial abnormalities NEC,Cytoplasmic disorders congenital,Cong,N
1112,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1113,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1113,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1113,3,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
1113,4,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1114,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1114,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1115,1,Drug exposure before pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1115,2,Ectopic pregnancy,Maternal complications of pregnancy NEC,Maternal complications of pregnancy,Preg,N
1116,1,Bladder pain,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1116,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1116,3,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1116,4,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1116,5,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1116,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1116,7,Gingival ulceration,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
1116,8,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1116,9,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1116,10,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1116,11,Tongue ulceration,Tongue disorders,Tongue conditions,Gastr,N
1117,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1117,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1118,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1118,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1119,1,Lacunar stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1120,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1120,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1121,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1121,2,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1122,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
1123,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1123,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1124,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1124,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1124,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1125,1,Anal incontinence,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1125,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1125,3,Areflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
1125,4,Aspiration,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1125,5,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1125,6,Central obesity,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1125,7,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1125,8,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1125,9,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1125,10,Increased tendency to bruise,Bleeding tendencies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1125,11,Infection susceptibility increased,Infections NEC,Infections - pathogen unspecified,Infec,N
1125,12,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1125,13,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1125,14,Keloid scar,Skin dystrophies,Cornification and dystrophic skin disorders,Skin,N
1125,15,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
1125,16,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
1125,17,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1125,18,Myalgia,Muscle pains,Muscle disorders,Musc,N
1125,19,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
1125,20,Skin striae,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
1125,21,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1125,22,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1125,23,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1125,24,Urine output decreased,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
1126,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1126,2,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
1127,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1127,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1127,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1127,4,Small for dates baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1128,1,Agoraphobia,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
1129,1,Dental discomfort,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
1129,2,Loose tooth,Dental disorders NEC,Dental and gingival conditions,Gastr,N
1129,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1129,4,Tooth injury,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
1130,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1131,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,Y
1131,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1131,3,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1131,4,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
1131,5,Cleft lip and palate,Palate disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
1131,6,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1131,7,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1131,8,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1131,9,Hepatic cytolysis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1131,10,Hydrops foetalis,Foetal complications NEC,Foetal complications,Preg,N
1131,11,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1131,12,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1131,13,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1131,14,Trisomy 18,Autosomal chromosomal abnormalities,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
1131,15,Ultrasound antenatal screen,Foetal and neonatal imaging procedures,Foetal and neonatal investigations,Inv,N
1132,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1132,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1132,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1132,4,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
1133,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1133,2,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1134,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1135,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1135,2,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1135,3,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1135,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1136,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1136,2,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1136,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1136,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1137,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1138,1,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1138,2,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1138,3,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1139,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1139,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1139,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1140,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1140,2,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1140,3,Hepatic pain,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
1140,4,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1140,5,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1141,1,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
1141,2,Viral mutation identified,Virus identification and serology,Microbiology and serology investigations,Inv,N
1142,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1142,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1142,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1142,4,Pancreatic disorder,Pancreatic disorders NEC,Exocrine pancreas conditions,Gastr,N
1142,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1142,6,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1143,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1143,2,Headache,Headaches NEC,Headaches,Nerv,N
1143,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1143,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1144,1,Vascular dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
1145,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1145,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1146,1,Retinal aneurysm,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
1147,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1147,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1147,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1148,1,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1148,2,Secondary adrenocortical insufficiency,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
1149,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1149,2,Secondary adrenocortical insufficiency,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
1150,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1150,2,Secondary adrenocortical insufficiency,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
1151,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1151,2,Secondary adrenocortical insufficiency,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
1152,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1152,2,Secondary adrenocortical insufficiency,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
1153,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1153,2,Secondary adrenocortical insufficiency,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
1154,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1154,2,Secondary adrenocortical insufficiency,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
1155,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1155,2,Secondary adrenocortical insufficiency,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
1156,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1156,2,Secondary adrenocortical insufficiency,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
1157,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1157,2,Secondary adrenocortical insufficiency,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
1158,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1158,2,Secondary adrenocortical insufficiency,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
1159,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1159,2,Secondary adrenocortical insufficiency,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
1160,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1160,2,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
1161,1,Agoraphobia,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
1161,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1161,3,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
1161,4,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1161,5,Clumsiness,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1161,6,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1161,7,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1161,8,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1161,9,Disturbance in social behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1161,10,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1161,11,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1161,12,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1161,13,Formication,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1161,14,Grip strength decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1161,15,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1161,16,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1161,17,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1161,18,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1161,19,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
1161,20,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1161,21,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1161,22,Neurodermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1161,23,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1161,24,Patient isolation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1161,25,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1161,26,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1161,27,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1161,28,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
1161,29,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1161,30,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1161,31,Scratch,Skin injuries NEC,Injuries NEC,Inj&P,N
1161,32,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1161,33,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1161,34,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1161,35,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1161,36,Skin hypertrophy,Skin hyperplasias and hypertrophies,Cornification and dystrophic skin disorders,Skin,N
1161,37,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1162,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1162,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1162,3,Small for dates baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1163,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1163,2,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
1163,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1164,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1165,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1166,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1167,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1168,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1168,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1168,3,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1169,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1170,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
1170,2,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
1170,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1170,4,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1170,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1170,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1171,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1172,1,Metastases to lymph nodes,Metastases to specified sites,Metastases,Neopl,N
1173,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1174,1,Hyperlipidaemia,Hyperlipidaemias NEC,Lipid metabolism disorders,Metab,N
1174,2,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1175,1,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1175,2,Sepsis syndrome,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1176,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1177,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1178,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1179,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1180,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1180,2,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1180,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1181,1,Fibrous histiocytoma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
1181,2,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1181,3,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1181,4,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1182,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1183,1,Coronavirus infection,Coronavirus infections,Viral infectious disorders,Infec,N
1184,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1185,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1186,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1187,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1188,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1189,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1189,2,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
1190,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1190,2,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
1191,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1191,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1191,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1192,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1193,1,Brain stem stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1193,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1193,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1194,1,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1194,2,Cervical vertebral fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
1195,1,Ankle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1196,1,Ear disorder,Ear disorders NEC,Aural disorders NEC,Ear,N
1196,2,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1196,3,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
1196,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1197,1,Congenital central nervous system anomaly,Central nervous system disorders congenital NEC,Neurological disorders congenital,Cong,N
1197,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1197,3,Pulmonary hypoplasia,Pulmonary and bronchial disorders congenital,Respiratory disorders congenital,Cong,N
1198,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1198,2,Stillbirth,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
1199,1,Auditory disorder,Hearing disorders NEC,Hearing disorders,Ear,N
1199,2,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1199,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1200,1,Coronavirus infection,Coronavirus infections,Viral infectious disorders,Infec,N
1201,1,Migraine,Migraine headaches,Headaches,Nerv,N
1201,2,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1202,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,Y
1203,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1204,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1204,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1205,1,General physical condition abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1206,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1206,2,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1207,1,Delayed puberty,Endocrine abnormalities of puberty,Endocrine disorders of gonadal function,Endo,N
1207,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1207,3,Failure to thrive,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1207,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1208,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1208,2,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1209,1,Lip discolouration,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1209,2,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
1209,3,Lipoedema,Lipid metabolism and deposit disorders NEC,Lipid metabolism disorders,Metab,N
1209,4,Low density lipoprotein increased,Cholesterol analyses,Lipid analyses,Inv,N
1209,5,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1209,6,Nail discolouration,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
1209,7,Nerve injury,Nerve injuries NEC,Injuries NEC,Inj&P,N
1209,8,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1209,9,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1209,10,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1210,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1210,2,Ovarian failure,Ovarian and fallopian tube disorders NEC,Ovarian and fallopian tube disorders,Repro,N
1211,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
1211,2,Delayed puberty,Endocrine abnormalities of puberty,Endocrine disorders of gonadal function,Endo,N
1211,3,Infertility,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
1211,4,Ovarian failure,Ovarian and fallopian tube disorders NEC,Ovarian and fallopian tube disorders,Repro,N
1212,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1212,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1212,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1213,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1213,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1213,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1213,4,Headache,Headaches NEC,Headaches,Nerv,N
1213,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1213,6,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1214,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1215,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1215,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1216,1,Product use complaint,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1217,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1217,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1218,1,Bone disorder,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1218,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1218,3,Multiple fractures,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
1219,1,Retinal toxicity,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
1220,1,Retinal toxicity,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
1221,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1222,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1223,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1224,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1224,2,Spina bifida,Central nervous system disorders congenital NEC,Neurological disorders congenital,Cong,N
1225,1,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
1225,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1226,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1226,2,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
1227,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1228,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1229,1,Injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1229,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1230,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1231,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1232,1,Prescription drug used without a prescription,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1233,1,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1233,2,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
1233,3,Myopathy,Myopathies,Muscle disorders,Musc,N
1234,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
1234,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
1234,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1234,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1234,5,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
1234,6,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1234,7,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1235,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1235,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1236,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1237,1,Prescription drug used without a prescription,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1238,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1239,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1240,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1240,2,Dialysis,Renal therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
1241,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1241,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1241,3,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1241,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1242,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1243,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1243,2,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1243,3,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
1243,4,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
1244,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1244,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1244,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1245,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1245,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1246,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1246,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1246,3,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1246,4,Hormone level abnormal,Endocrine analyses and imaging NEC,Endocrine investigations (incl sex hormones),Inv,N
1246,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1246,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1246,7,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1247,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1247,2,Hypercholesterolaemia,Elevated cholesterol,Lipid metabolism disorders,Metab,N
1248,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1248,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1249,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1249,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1250,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1251,1,Eating disorder,Eating disorders NEC,Eating disorders and disturbances,Psych,N
1251,2,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1252,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1252,2,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1253,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1254,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1255,1,Headache,Headaches NEC,Headaches,Nerv,N
1255,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1256,1,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1256,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1256,3,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1257,1,Congenital hydrocephalus,Cerebral disorders congenital,Neurological disorders congenital,Cong,N
1257,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1258,1,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1258,2,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1258,3,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1259,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1260,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1261,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1261,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1262,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1262,2,Secondary adrenocortical insufficiency,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
1263,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1263,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1263,3,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1263,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1264,1,Craniofacial deformity,Musculoskeletal and connective tissue disorders of skull congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
1264,2,Foetal chromosome abnormality,Chromosomal abnormalities NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
1264,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1264,4,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1264,5,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
1264,6,Trisomy 21,Autosomal chromosomal abnormalities,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
1264,7,Ultrasound antenatal screen,Foetal and neonatal imaging procedures,Foetal and neonatal investigations,Inv,N
1265,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1265,2,Hyperadrenocorticism,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1265,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1265,4,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1265,5,Plethoric face,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1265,6,Pseudo Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1265,7,Skin striae,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
1266,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1266,2,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1267,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1268,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
1268,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1268,3,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1268,4,Muscle injury,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
1268,5,Physical assault,Criminal activity,Legal issues,SocCi,N
1269,1,Headache,Headaches NEC,Headaches,Nerv,N
1269,2,Nasal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1270,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1270,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1271,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1271,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1272,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1272,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1273,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1273,2,Eructation,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1273,3,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1274,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1274,2,Eructation,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1274,3,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1275,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1276,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1277,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1277,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1277,3,Headache,Headaches NEC,Headaches,Nerv,N
1277,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1277,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1278,1,Headache,Headaches NEC,Headaches,Nerv,N
1279,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1280,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1281,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1282,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1283,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1284,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1285,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1286,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1286,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1287,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1287,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1287,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1288,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1288,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1289,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1289,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1290,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1291,1,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1292,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1292,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1293,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1293,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1293,3,Faeces discoloured,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
1294,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1294,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1295,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1296,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1296,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1297,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1297,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1298,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1298,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1299,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1299,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1299,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1299,4,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1299,5,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
1299,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1300,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1300,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1300,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1300,4,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1301,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1302,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1303,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
1303,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1303,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1303,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1304,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1305,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1305,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1306,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1307,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1308,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1309,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1310,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1311,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1311,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1311,3,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1312,1,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1313,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1313,2,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
1314,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1314,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1315,1,Headache,Headaches NEC,Headaches,Nerv,N
1316,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1317,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1317,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1318,1,Blood pressure fluctuation,Blood pressure disorders NEC,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1318,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1318,3,Heart rate variability increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1318,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1319,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1320,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1321,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1322,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1322,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1323,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1323,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1323,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1323,4,Headache,Headaches NEC,Headaches,Nerv,N
1323,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1323,6,Product after taste,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1324,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1324,2,Polymenorrhoea,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
1325,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1325,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1326,1,Breath odour,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1327,1,Drooling,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1327,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1327,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1327,4,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1328,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1329,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1330,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1330,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1331,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1331,2,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1332,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1333,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1334,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1335,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1336,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1336,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1337,1,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1338,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1338,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1338,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1339,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1339,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1339,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1340,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1341,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1341,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1341,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1342,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1343,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1343,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1343,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1343,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1344,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1344,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1344,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1344,4,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1344,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1344,6,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1344,7,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1344,8,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1344,9,Myalgia,Muscle pains,Muscle disorders,Musc,N
1344,10,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1344,11,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1344,12,Plicated tongue,Tongue disorders,Tongue conditions,Gastr,N
1344,13,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1344,14,Tongue discolouration,Tongue signs and symptoms,Tongue conditions,Gastr,N
1345,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1346,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1347,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
1347,2,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1347,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1348,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1348,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1349,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1350,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1350,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1350,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1351,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1352,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1352,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1352,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1353,1,Eructation,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1353,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1353,3,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1354,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1354,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1354,3,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1354,4,Headache,Headaches NEC,Headaches,Nerv,N
1354,5,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1354,6,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1355,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1355,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1355,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1355,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1356,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1357,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1357,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1358,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1358,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1359,1,Debridement,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1359,2,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
1359,3,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1360,1,Coronavirus test,Virus identification and serology,Microbiology and serology investigations,Inv,N
1360,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1360,3,Headache,Headaches NEC,Headaches,Nerv,N
1360,4,Headache,Headaches NEC,Headaches,Nerv,N
1360,5,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1361,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1362,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1362,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1362,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1363,1,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1364,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1364,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1364,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1364,4,Headache,Headaches NEC,Headaches,Nerv,N
1364,5,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1364,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1364,7,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1365,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1365,2,Headache,Headaches NEC,Headaches,Nerv,N
1365,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1365,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1365,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1365,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1366,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1366,2,Headache,Headaches NEC,Headaches,Nerv,N
1367,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1368,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1369,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1369,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1370,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1370,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1370,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1371,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1371,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1371,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1372,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1373,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1374,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1374,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1375,1,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1375,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1375,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1376,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1377,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1378,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1379,1,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1380,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1381,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1382,1,Anal spasm,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
1382,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1382,3,Proctalgia,Anal and rectal pains,Anal and rectal conditions NEC,Gastr,N
1383,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1384,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1384,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1385,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1386,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1387,1,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1388,1,Dizziness postural,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1388,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1388,3,Morning sickness,Maternal complications of pregnancy NEC,Maternal complications of pregnancy,Preg,N
1389,1,Analgesic drug level,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1389,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1390,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1391,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1391,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1392,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1393,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1393,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1394,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1394,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
1394,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1395,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1396,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1396,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1397,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1398,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1398,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1399,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1399,2,Anosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1399,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1400,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1401,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1401,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1402,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1403,1,Headache,Headaches NEC,Headaches,Nerv,N
1404,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1404,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1405,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1405,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1406,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1407,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1407,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1408,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1408,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1408,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1409,1,Parosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1409,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1410,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1411,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1412,1,Micturition frequency decreased,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1412,2,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1413,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1414,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1414,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1415,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1415,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1416,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1416,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1417,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1418,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1419,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1419,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1419,3,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1420,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1420,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1421,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1421,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1422,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1423,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1424,1,Urine output,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
1425,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1425,2,Headache,Headaches NEC,Headaches,Nerv,N
1426,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1427,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1427,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1428,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
1429,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1430,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1431,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1431,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1432,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1433,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1434,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1435,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1435,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1436,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
1437,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1438,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1438,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1439,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1440,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1440,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1440,3,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1441,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1442,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1442,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1443,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1444,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1444,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1444,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1445,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1446,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1446,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1446,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1446,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1446,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1446,6,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1446,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1446,8,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1447,1,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1448,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1448,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1448,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1448,4,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1448,5,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1448,6,Product use complaint,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1448,7,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1448,8,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1449,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1450,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1450,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1451,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1452,1,Consciousness fluctuating,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1452,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1452,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1452,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1453,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1453,2,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1454,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1454,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1455,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1455,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1455,3,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1456,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1457,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1457,2,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1458,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1459,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1459,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1459,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1460,1,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1461,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1462,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1463,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1464,1,Non-cardiac chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1464,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1465,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1465,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1466,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1467,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1468,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1468,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1468,3,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1468,4,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1469,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1469,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1469,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1469,4,Gastrointestinal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1470,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1471,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1471,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1472,1,Migraine,Migraine headaches,Headaches,Nerv,N
1472,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1473,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1474,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1474,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1475,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1476,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1477,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1478,1,Parosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1478,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1479,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1479,2,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1480,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1481,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1482,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1482,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1482,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1482,4,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1483,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1484,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1485,1,Sudden hearing loss,Hearing losses,Hearing disorders,Ear,N
1486,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1486,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1486,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1486,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1486,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1487,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1487,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1487,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1487,4,Headache,Headaches NEC,Headaches,Nerv,N
1488,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1489,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1489,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1490,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1491,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1492,1,Headache,Headaches NEC,Headaches,Nerv,N
1492,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1492,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1493,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1494,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1494,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1495,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1496,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1497,1,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
1498,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1499,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1500,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1500,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1501,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1502,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1503,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1504,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1505,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1505,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1505,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1506,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1507,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1508,1,Skin sensitisation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1509,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1510,1,Faeces discoloured,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
1511,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1512,1,Body temperature abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1512,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1512,3,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1513,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1513,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1513,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1513,4,Headache,Headaches NEC,Headaches,Nerv,N
1513,5,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1514,1,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
1515,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1516,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1516,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1517,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1518,1,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
1519,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1520,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1521,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1521,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1521,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1521,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1521,5,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1522,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1523,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1524,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1525,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1525,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1526,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1526,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1527,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1527,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1528,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1528,2,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
1529,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1529,2,Anosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1529,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1529,4,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1530,1,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1531,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1532,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1532,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1532,3,Faeces soft,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
1532,4,Flank pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1532,5,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1532,6,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1533,1,Headache,Headaches NEC,Headaches,Nerv,N
1533,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1534,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1534,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1535,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1536,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1536,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1536,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1537,1,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1538,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1538,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1538,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1538,4,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1539,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1539,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1540,1,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1541,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1541,2,Tongue coated,Tongue signs and symptoms,Tongue conditions,Gastr,N
1542,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1542,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1543,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1544,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1545,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1546,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1547,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1547,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1548,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1549,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1550,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1550,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1550,3,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1551,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1551,2,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1551,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1551,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1551,5,Reflux laryngitis,Laryngeal and adjacent sites disorders NEC (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1551,6,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1552,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1552,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1553,1,Headache,Headaches NEC,Headaches,Nerv,N
1554,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1555,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1556,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1556,2,Headache,Headaches NEC,Headaches,Nerv,N
1557,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1557,2,Headache,Headaches NEC,Headaches,Nerv,N
1557,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1557,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1558,1,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1559,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1559,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1560,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1560,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1560,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1561,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1561,2,Gastrointestinal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1562,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1563,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1563,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1564,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1565,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1565,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1566,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1566,2,Parosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1567,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1567,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1568,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1569,1,Headache,Headaches NEC,Headaches,Nerv,N
1569,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1570,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1571,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1572,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1573,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1574,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1574,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1575,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1576,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1576,2,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1577,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1577,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1578,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1579,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1579,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1580,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1581,1,Menstrual disorder,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
1581,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1582,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1582,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1582,3,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1582,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1582,5,Vomiting projectile,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1583,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1584,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1585,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1586,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1586,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1586,3,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1587,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1588,1,Anal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1588,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1588,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1589,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1590,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1591,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1591,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1592,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1593,1,Product after taste,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1594,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1595,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1596,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1597,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1598,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1599,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1599,2,Plicated tongue,Tongue disorders,Tongue conditions,Gastr,N
1600,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1601,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1602,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1603,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1604,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1604,2,Renal pain,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
1605,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1605,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1606,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1606,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1607,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1607,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1608,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1609,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1610,1,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1611,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1612,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1612,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1613,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1613,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1614,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1614,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1615,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1616,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1617,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1617,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1617,3,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1618,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1618,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1618,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1618,4,Yawning,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1619,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1620,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1621,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1621,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1622,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1622,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1623,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1623,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1623,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1623,4,Headache,Headaches NEC,Headaches,Nerv,N
1623,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1623,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1624,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1625,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1625,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1626,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1626,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1626,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1626,4,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1627,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1627,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1628,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1628,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1628,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1629,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1629,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1630,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1630,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1630,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1631,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1632,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1632,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1632,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1632,4,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1633,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1634,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1635,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1636,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1636,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1637,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1637,2,Anosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1637,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1638,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1639,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1640,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1641,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1641,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1642,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1642,2,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
1642,3,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1642,4,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1642,5,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1642,6,Urine abnormality,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1643,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1643,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1644,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1644,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1644,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1645,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1645,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1645,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1646,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1647,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1647,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1648,1,Anosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1648,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1648,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1649,1,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1650,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1651,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1651,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1651,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1652,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1652,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1652,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1652,4,Headache,Headaches NEC,Headaches,Nerv,N
1653,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1653,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1653,3,Headache,Headaches NEC,Headaches,Nerv,N
1654,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1654,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1655,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1656,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1656,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1657,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1657,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1658,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1659,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1660,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1661,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1661,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1661,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1661,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1661,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1661,6,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1661,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1662,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1662,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1662,3,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1663,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1664,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1664,2,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1665,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1665,2,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1665,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1665,4,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1666,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1666,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1667,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1667,2,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1667,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1667,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1667,5,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1667,6,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1667,7,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1667,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1667,9,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1667,10,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1668,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1668,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1669,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1670,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1671,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1671,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1672,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1672,2,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1672,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1673,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1674,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1674,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1674,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1674,4,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1674,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1674,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1675,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1676,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1677,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1678,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1679,1,Blood disorder,Haematological disorders,Haematological disorders NEC,Blood,N
1679,2,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1679,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1679,4,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1680,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1680,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1681,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1681,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1682,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1683,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1683,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1684,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1684,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1684,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1684,4,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1684,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1685,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1685,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1686,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1686,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1686,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1686,4,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1686,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1687,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1688,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1689,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1689,2,Lip dry,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1690,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1691,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1692,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1693,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1694,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1695,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1695,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1695,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1695,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1696,1,Discharge,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1697,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1698,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1699,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1700,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1701,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1701,2,Product after taste,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1702,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1702,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1703,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1703,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1704,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1704,2,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1705,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1705,2,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1706,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1706,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1707,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1707,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1707,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1707,4,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1707,5,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1707,6,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1707,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1707,8,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1707,9,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
1707,10,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1707,11,Parosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1707,12,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
1707,13,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1707,14,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1707,15,Secretion discharge,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1707,16,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1707,17,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1708,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1708,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1709,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1710,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1711,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1711,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1711,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1712,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1713,1,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1713,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1714,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1715,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1715,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1716,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1716,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1716,3,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1717,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1717,2,Gastric dilatation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1717,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1718,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1718,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1718,3,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
1718,4,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1718,5,Headache,Headaches NEC,Headaches,Nerv,N
1718,6,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1718,7,Malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
1718,8,Malnutrition,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1718,9,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1718,10,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
1718,11,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1718,12,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1718,13,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1718,14,Protein urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
1718,15,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
1718,16,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1719,1,Energy increased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1719,2,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1719,3,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
1719,4,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1720,1,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1721,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1722,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1722,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1723,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1724,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1724,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1724,3,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1724,4,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
1724,5,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1725,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1726,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1726,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1726,3,Migraine,Migraine headaches,Headaches,Nerv,N
1726,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1727,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
1727,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1727,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1727,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1727,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1728,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1728,2,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1729,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1729,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1729,3,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
1729,4,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1729,5,Headache,Headaches NEC,Headaches,Nerv,N
1729,6,Malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
1729,7,Malnutrition,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1729,8,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1729,9,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
1729,10,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1729,11,Protein urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
1729,12,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1730,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1731,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1731,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1731,3,Headache,Headaches NEC,Headaches,Nerv,N
1731,4,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
1731,5,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1731,6,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1731,7,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1731,8,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1732,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1733,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1733,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1734,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1734,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1734,3,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1734,4,Headache,Headaches NEC,Headaches,Nerv,N
1734,5,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
1734,6,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1734,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1734,8,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1734,9,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1735,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1735,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
1735,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1736,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1737,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1738,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1738,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1738,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1739,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1739,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1739,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1739,4,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1740,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1740,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1741,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1742,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1742,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1743,1,Headache,Headaches NEC,Headaches,Nerv,N
1744,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1745,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1746,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1747,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1748,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1748,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1749,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1750,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1750,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1750,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1750,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1751,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1751,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1752,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1752,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1752,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1752,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1753,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1754,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1755,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1755,2,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1755,3,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1756,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1756,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1756,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1757,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1757,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1758,1,Headache,Headaches NEC,Headaches,Nerv,N
1758,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1758,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1759,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1760,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1761,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1762,1,Catarrh,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1762,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1763,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1764,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1765,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1766,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1766,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1766,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1766,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1767,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1767,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1767,3,Hypogeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1768,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1768,2,Gastrointestinal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1768,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1768,4,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1769,1,Saliva altered,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1770,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1770,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1771,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1772,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1773,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1774,1,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1775,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1776,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1776,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1777,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1778,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1779,1,Urine output,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
1780,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1781,1,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1782,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1782,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1783,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1784,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1785,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1785,2,Dry throat,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1785,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1785,4,Headache,Headaches NEC,Headaches,Nerv,N
1785,5,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1785,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1785,7,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1786,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1786,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1787,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1788,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1789,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1789,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1789,3,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1790,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1790,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1790,3,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1791,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1791,2,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1791,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1791,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1792,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1792,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1793,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1794,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1795,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1795,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1796,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1796,2,Headache,Headaches NEC,Headaches,Nerv,N
1797,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1798,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1798,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1799,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1799,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1800,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1800,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1801,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1801,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1801,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1801,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1801,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1801,6,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1802,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1802,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1802,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1802,4,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
1802,5,Neurosarcoidosis,Central nervous system inflammatory disorders NEC,Central nervous system infections and inflammations,Nerv,N
1802,6,Pulmonary sarcoidosis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1802,7,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1802,8,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1803,1,Headache,Headaches NEC,Headaches,Nerv,N
1803,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1803,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1804,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1804,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1804,3,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1804,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1804,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1805,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1805,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1806,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1807,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1808,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1808,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1808,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1809,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1809,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1810,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1810,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1810,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1810,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1811,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1811,2,Headache,Headaches NEC,Headaches,Nerv,N
1811,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1811,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1812,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1813,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1813,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1813,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1813,4,Headache,Headaches NEC,Headaches,Nerv,N
1813,5,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
1813,6,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1813,7,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1814,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1814,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1815,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1815,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1816,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1817,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1817,2,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
1817,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1818,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1818,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1818,3,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1818,4,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1818,5,Hepatic cytolysis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
1818,6,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1818,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1819,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1819,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1820,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1821,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1821,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1822,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1822,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1823,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1823,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1823,3,Headache,Headaches NEC,Headaches,Nerv,N
1823,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1823,5,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
1824,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1825,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1825,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1825,3,Product size issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1825,4,Product use complaint,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1826,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1826,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1826,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1827,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1828,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1829,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1830,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1831,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1831,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1832,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1832,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1833,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1833,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1833,3,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
1834,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1835,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1835,2,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1835,3,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1835,4,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1835,5,Migraine,Migraine headaches,Headaches,Nerv,N
1835,6,Myalgia,Muscle pains,Muscle disorders,Musc,N
1835,7,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1835,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1836,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1836,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1837,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1838,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1838,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1839,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1840,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1840,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1840,3,Faeces soft,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
1840,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1841,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1842,1,Otitis externa,Ear infections,Infections - pathogen unspecified,Infec,N
1843,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1843,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1843,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1844,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1844,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1845,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1845,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1846,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1846,2,Headache,Headaches NEC,Headaches,Nerv,N
1847,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1848,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1849,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1850,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1851,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1851,2,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1851,3,Oesophageal spasm,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1852,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1853,1,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1854,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1854,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1855,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1856,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1856,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1856,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1857,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1857,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1857,3,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1858,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1859,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1859,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1860,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1861,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1861,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1862,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1862,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1863,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1863,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1864,1,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1865,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1865,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1866,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1866,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1867,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1867,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1867,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1868,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1868,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1869,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1869,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1869,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1870,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1870,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1870,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1870,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1871,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1871,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1871,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1871,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1872,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1872,2,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1873,1,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
1873,2,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1873,3,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1873,4,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1874,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1874,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1874,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1874,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1875,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1876,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1877,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1878,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1878,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1879,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1880,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1881,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1882,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1882,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1883,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1884,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1885,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1885,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1885,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1885,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1886,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1886,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1887,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1888,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1889,1,Faeces discoloured,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
1890,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1891,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1892,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1892,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1893,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1893,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1893,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1894,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1895,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1896,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1896,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1897,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
1897,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1898,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1899,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
1900,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1900,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1901,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1902,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1902,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1903,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1904,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1904,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1905,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1906,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1906,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1906,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1907,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1907,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1907,3,Gastrointestinal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1907,4,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1908,1,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1908,2,Intraventricular haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1909,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1909,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1910,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1910,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1910,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1910,4,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1911,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1912,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1913,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1913,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1914,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1914,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1915,1,Symptom recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1916,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1917,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1917,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1917,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1918,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1919,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1920,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1920,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1920,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1921,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1921,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1922,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1922,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1923,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1924,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1924,2,Glossodynia,Tongue signs and symptoms,Tongue conditions,Gastr,N
1924,3,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1924,4,Tongue discolouration,Tongue signs and symptoms,Tongue conditions,Gastr,N
1925,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1925,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1925,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1926,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1927,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1928,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1929,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1929,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1930,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1930,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1931,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1932,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1932,2,Headache,Headaches NEC,Headaches,Nerv,N
1933,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1934,1,Therapeutic product effect increased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1935,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1935,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1935,3,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
1936,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1937,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1937,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1937,3,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1938,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1939,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1940,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1941,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1942,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1943,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1943,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1943,3,Headache,Headaches NEC,Headaches,Nerv,N
1943,4,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1944,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1945,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1945,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1945,3,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1946,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1947,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1948,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1949,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1950,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1951,1,Increased viscosity of upper respiratory secretion,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1952,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1953,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1954,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1955,1,Oxygen saturation increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1955,2,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1956,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1956,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1957,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1957,2,Gastrointestinal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1958,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1958,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1959,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1959,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1960,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1960,2,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
1961,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1962,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1962,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1963,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1963,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1964,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1964,2,Headache,Headaches NEC,Headaches,Nerv,N
1964,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1965,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1965,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1966,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1966,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1967,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1967,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1968,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1969,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1969,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1970,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1971,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1971,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1972,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1973,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1973,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1974,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1975,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1975,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1975,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1975,4,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1976,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1977,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1978,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1979,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1980,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1980,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1980,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1980,4,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1981,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1982,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1983,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1984,1,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1984,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1984,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1985,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1986,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1987,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1987,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1988,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1989,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1989,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1989,3,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1989,4,Headache,Headaches NEC,Headaches,Nerv,N
1990,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1991,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1991,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1992,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1993,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1994,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1994,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1995,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1995,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1995,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1996,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1996,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1996,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1997,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1998,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1998,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1999,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1999,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1999,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1999,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1999,5,Feeling drunk,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1999,6,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1999,7,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1999,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2000,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2001,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2002,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2003,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2003,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2004,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2004,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2005,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2006,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2006,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2007,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2008,1,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2009,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2010,1,Anosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
2010,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2010,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2010,4,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
2011,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2011,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2011,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2012,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2012,2,Lichen planus,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
2012,3,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
2013,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2014,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2015,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2015,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2016,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2017,1,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2018,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2019,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2019,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2020,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2020,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2021,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2022,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2023,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2024,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2024,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2024,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2024,4,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2025,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2026,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2026,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2027,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2027,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2028,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2028,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2029,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2029,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2030,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2031,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
2032,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2032,2,Menstruation delayed,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
2032,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2033,1,Headache,Headaches NEC,Headaches,Nerv,N
2033,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2033,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2034,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2035,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2036,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2036,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2036,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2036,4,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2036,5,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2037,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2037,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2037,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2037,4,Headache,Headaches NEC,Headaches,Nerv,N
2037,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2037,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2038,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2039,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2039,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2040,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2041,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2041,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
2041,3,Headache,Headaches NEC,Headaches,Nerv,N
2041,4,Muscle tightness,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2041,5,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2041,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2041,7,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2041,8,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
2041,9,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2041,10,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
2042,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2042,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2042,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2043,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2044,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2044,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2045,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2046,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2046,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2047,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2048,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2049,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2049,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2050,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2050,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2050,3,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2051,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2052,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2052,2,Product after taste,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2053,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2053,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2053,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2054,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2054,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2054,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2055,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2056,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2056,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2056,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2056,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2057,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2057,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2058,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2059,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2059,2,Anosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
2059,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2060,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2060,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2061,1,Groin pain,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2062,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2062,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2063,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2064,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2064,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2064,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2065,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2065,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2066,1,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
2067,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2067,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2068,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2069,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2070,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2071,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2072,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2073,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2073,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2073,3,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2073,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
2074,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2074,2,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2074,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2075,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2076,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2077,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2077,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2078,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2079,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2080,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2081,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2082,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2083,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2083,2,Headache,Headaches NEC,Headaches,Nerv,N
2084,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2084,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2084,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2084,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2084,5,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
2085,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2085,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2086,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2086,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2087,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2088,1,Anorectal discomfort,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
2089,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2090,1,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2091,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2091,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2092,1,Lip blister,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
2092,2,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
2093,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2093,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2094,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2094,2,Product taste abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2095,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2096,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2097,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2098,1,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
2099,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2100,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2100,2,Headache,Headaches NEC,Headaches,Nerv,N
2101,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2101,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2102,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2102,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2102,3,Headache,Headaches NEC,Headaches,Nerv,N
2102,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2103,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2104,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2105,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2106,1,Hyperchlorhydria,Gastrointestinal mucosal dystrophies and secretion disorders,Gastrointestinal conditions NEC,Gastr,N
2107,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2108,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2109,1,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2110,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2110,2,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
2111,1,Tongue discomfort,Tongue signs and symptoms,Tongue conditions,Gastr,N
2112,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2112,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2112,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2113,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2114,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2114,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2115,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2116,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2116,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2116,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2116,4,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2117,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2117,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2117,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2117,4,Product use complaint,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2117,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2118,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2118,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2118,3,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2118,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2118,5,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2118,6,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2119,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2120,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2121,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2121,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2122,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2122,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2122,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2123,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2124,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
2125,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2126,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2127,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2127,2,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2128,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2129,1,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
2129,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2130,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2131,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2131,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2132,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2133,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2133,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2134,1,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2134,2,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2135,1,Saliva altered,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
2135,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2136,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2136,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2137,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2137,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2138,1,Menstruation delayed,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
2139,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2139,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2140,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2141,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2141,2,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2142,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2142,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2142,3,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2142,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2142,5,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
2143,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2143,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2144,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2145,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2145,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2145,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2145,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2146,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2147,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2148,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2149,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2150,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2151,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2151,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2152,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2153,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2153,2,Headache,Headaches NEC,Headaches,Nerv,N
2154,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2154,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2155,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2156,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2156,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2157,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2158,1,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2159,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2160,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2160,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2161,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2161,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2162,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2162,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2163,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2164,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2165,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2165,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2166,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2167,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2167,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2168,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2169,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2170,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2171,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2172,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2172,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2172,3,Headache,Headaches NEC,Headaches,Nerv,N
2172,4,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2172,5,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2172,6,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2173,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2174,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2175,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2176,1,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
2177,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2177,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2178,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2179,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2179,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2180,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2180,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2181,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2182,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2183,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2184,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2185,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2185,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2185,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2185,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2186,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2187,1,Dry throat,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2187,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2187,3,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2188,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2189,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2189,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2190,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
2190,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2190,3,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2191,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2192,1,Deafness bilateral,Hearing losses,Hearing disorders,Ear,N
2192,2,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
2192,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2192,4,Product administered to patient of inappropriate age,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2193,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2193,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2194,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2194,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2195,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2196,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2196,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2197,1,Headache,Headaches NEC,Headaches,Nerv,N
2198,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2198,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2198,3,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2199,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2200,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2200,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2200,3,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
2200,4,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
2200,5,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2200,6,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2201,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2201,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2202,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2203,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2203,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2204,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2204,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2205,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2205,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2205,3,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
2206,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2207,1,Brain stem stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2207,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2207,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2208,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2208,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2209,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2210,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2211,1,Deafness,Hearing losses,Hearing disorders,Ear,N
2211,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2212,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2213,1,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2213,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2213,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2214,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2214,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2215,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2215,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2216,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2217,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2218,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2219,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2219,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2220,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2220,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2220,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2221,1,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2222,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2223,1,Product after taste,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2224,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
2224,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2225,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2225,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2226,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2227,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2227,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2227,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2228,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2229,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2230,1,Menstrual disorder,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
2231,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2232,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2232,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2233,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2234,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2234,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2234,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2235,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2235,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2236,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
2236,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2236,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2236,4,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2237,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2237,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2237,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2237,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2237,5,Headache,Headaches NEC,Headaches,Nerv,N
2237,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2238,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2239,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2240,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2240,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2241,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2242,1,Migraine,Migraine headaches,Headaches,Nerv,N
2243,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2244,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2245,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2246,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2246,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2246,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2247,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2248,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2249,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2249,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2250,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2251,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2252,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2252,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2252,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2252,4,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2252,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2252,6,Headache,Headaches NEC,Headaches,Nerv,N
2252,7,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2252,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2252,9,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2253,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2254,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2255,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2256,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2256,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2257,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2258,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2258,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2259,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2260,1,Heart rate,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2261,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2262,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2262,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2262,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2262,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2263,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2264,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2264,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2264,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2265,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2266,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2267,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2267,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2267,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2268,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2268,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2268,3,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2269,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2270,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2271,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2271,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2271,3,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2272,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2273,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2274,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2274,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2275,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2276,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2276,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2277,1,Symptom recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2278,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2278,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2278,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2278,4,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
2279,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2280,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2281,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2282,1,Headache,Headaches NEC,Headaches,Nerv,N
2283,1,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2284,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2284,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2284,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
2285,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2286,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2286,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2287,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2287,2,Tongue rough,Tongue signs and symptoms,Tongue conditions,Gastr,N
2288,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2288,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2289,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2290,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2290,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2290,3,Headache,Headaches NEC,Headaches,Nerv,N
2290,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2291,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2292,1,Genotype drug resistance test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
2293,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2294,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2295,1,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2296,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2297,1,Glossodynia,Tongue signs and symptoms,Tongue conditions,Gastr,N
2297,2,Lip blister,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
2297,3,Proctalgia,Anal and rectal pains,Anal and rectal conditions NEC,Gastr,N
2297,4,Product after taste,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2298,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2298,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2298,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2298,4,Headache,Headaches NEC,Headaches,Nerv,N
2298,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2299,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2300,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2300,2,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2300,3,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2300,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2300,5,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
2300,6,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2300,7,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2300,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2300,9,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2301,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2302,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2302,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2302,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2302,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2303,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2303,2,Product after taste,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2304,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2304,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2305,1,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2306,1,Faeces discoloured,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
2307,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2307,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2307,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2308,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2309,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2309,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2310,1,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2311,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2312,1,Anosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
2312,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2312,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2313,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2313,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2314,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2314,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
2315,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2316,1,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2317,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2318,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2318,2,Product after taste,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2319,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2319,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2320,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2320,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2321,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2321,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2322,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2322,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2323,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2324,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2325,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2326,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2327,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2327,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2327,3,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2328,1,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2329,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2330,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2330,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2330,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2330,4,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2331,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2331,2,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
2331,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2331,4,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2331,5,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2331,6,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2331,7,Fluid intake reduced,Fluid intake decreased,Electrolyte and fluid balance conditions,Metab,N
2331,8,Headache,Headaches NEC,Headaches,Nerv,N
2331,9,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2331,10,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
2331,11,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2331,12,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2331,13,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2331,14,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2332,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2332,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2333,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2334,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2335,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2335,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2336,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2336,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2336,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2337,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2337,2,Headache,Headaches NEC,Headaches,Nerv,N
2337,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2338,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2338,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2338,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2338,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2339,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2339,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2340,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
2340,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2341,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2341,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2342,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2343,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2344,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2345,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2345,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2346,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2347,1,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2348,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2349,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2350,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2351,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2352,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2353,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
2353,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2353,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2353,4,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2353,5,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2354,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2354,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2354,3,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2354,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2354,5,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2354,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2354,7,Myalgia,Muscle pains,Muscle disorders,Musc,N
2354,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2354,9,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2354,10,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2355,1,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2356,1,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2357,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2358,1,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
2359,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2360,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2361,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2362,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2363,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2363,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2363,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2363,4,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2364,1,Sinus headache,Headaches NEC,Headaches,Nerv,N
2365,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
2365,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2365,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2365,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2366,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2366,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2366,3,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2367,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2367,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2368,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2369,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2370,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2371,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2372,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2372,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2373,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2373,2,Glossodynia,Tongue signs and symptoms,Tongue conditions,Gastr,N
2373,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
2374,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2375,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2376,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2377,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2377,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2377,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2378,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2378,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2378,3,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2379,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2379,2,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2380,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2381,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2382,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2383,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2384,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2384,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2384,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2384,4,Symptom recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2384,5,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2385,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2386,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2386,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2386,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2387,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2388,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2389,1,Headache,Headaches NEC,Headaches,Nerv,N
2389,2,Musculoskeletal chest pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2389,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2390,1,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
2391,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2391,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2391,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2392,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2393,1,Energy increased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2394,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2395,1,Pancreatitis relapsing,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
2396,1,Headache,Headaches NEC,Headaches,Nerv,N
2397,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2398,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2398,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2399,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2400,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2401,1,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2402,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2403,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2403,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2404,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2405,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2406,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2406,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2407,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2408,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2409,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2409,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2409,3,Headache,Headaches NEC,Headaches,Nerv,N
2409,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2410,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2410,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2411,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2412,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2413,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2413,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
2413,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2414,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2415,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2415,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2416,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2417,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2418,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2418,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2418,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2418,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2419,1,Headache,Headaches NEC,Headaches,Nerv,N
2420,1,Headache,Headaches NEC,Headaches,Nerv,N
2421,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2422,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2423,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2423,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2424,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2425,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2425,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2425,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2426,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2427,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2428,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2428,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2429,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2429,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2429,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2430,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2431,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2431,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2432,1,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2433,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2434,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2435,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2436,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
2437,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2438,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2438,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2439,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2439,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
2440,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2440,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2441,1,Foetal exposure during delivery,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2441,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2441,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2441,4,Renal aplasia,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
2441,5,Renal dysplasia,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
2441,6,Single functional kidney,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
2442,1,Reflux gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2443,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2443,2,Tension headache,Headaches NEC,Headaches,Nerv,N
2444,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2444,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2444,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2445,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2446,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2446,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2446,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2446,4,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2447,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2447,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
2448,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2448,2,Product after taste,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2449,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2450,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2451,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2451,2,Hand dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2451,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
2452,1,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2453,1,Headache,Headaches NEC,Headaches,Nerv,N
2454,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2454,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2454,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2454,4,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
2454,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2454,6,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2455,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2456,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2456,2,Middle insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2456,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2456,4,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2457,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2457,2,Saliva altered,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
2458,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2459,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2460,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2461,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2462,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2462,2,Renal pain,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
2463,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2464,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2465,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2466,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2467,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2468,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2469,1,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2470,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2471,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2472,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2472,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2473,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2473,2,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2474,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2475,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2476,1,Product after taste,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2477,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2478,1,Product formulation issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2479,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2480,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2480,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2481,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2482,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2483,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2484,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2485,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2485,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2485,3,SARS-CoV-2 test,Virus identification and serology,Microbiology and serology investigations,Inv,N
2486,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2487,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2488,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
2489,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2490,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2491,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
2492,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2492,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2492,3,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2492,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2492,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2493,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2493,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2493,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2493,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2494,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2495,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2496,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2496,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2496,3,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2497,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2498,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2498,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2498,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2499,1,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
2500,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2500,2,Headache,Headaches NEC,Headaches,Nerv,N
2501,1,Reflux gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2502,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2502,2,Parosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
2503,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2504,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2504,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2505,1,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2506,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2507,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2508,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2509,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2510,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2511,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
2512,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2512,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2513,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2514,1,Palliative care,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
2515,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2516,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2516,2,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2517,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2518,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2519,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2520,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2521,1,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2522,1,Palliative care,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
2523,1,Viral pharyngitis,Viral infections NEC,Viral infectious disorders,Infec,N
2524,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2525,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2526,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2527,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2528,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
2528,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2528,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2529,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2529,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2530,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2531,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2532,1,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2533,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2534,1,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2535,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2535,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2536,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
2537,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2538,1,Anal pruritus,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
2538,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2538,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2539,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
2540,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2541,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2541,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2541,3,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2541,4,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2541,5,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2542,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2543,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2544,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2545,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
2546,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2547,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2548,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2549,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2550,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
2551,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2552,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2553,1,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
2554,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2555,1,Headache,Headaches NEC,Headaches,Nerv,N
2555,2,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2556,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2557,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2558,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2559,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2560,1,Product after taste,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2561,1,Anosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
2561,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2562,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2563,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2563,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
2563,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2564,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2564,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2565,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2565,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
2565,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2566,1,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2567,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2567,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2567,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2568,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2568,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2569,1,Lip exfoliation,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2570,1,Polymerase chain reaction positive,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
2571,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2572,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2573,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2573,2,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2573,3,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
2573,4,Gingival pain,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
2573,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2573,6,Oesophageal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2573,7,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
2573,8,Tongue discomfort,Tongue signs and symptoms,Tongue conditions,Gastr,N
2574,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2575,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2576,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2577,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
2577,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2577,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2578,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
2579,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2580,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2581,1,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
2582,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2583,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2583,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2583,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2584,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2585,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2586,1,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2587,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2587,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2588,1,Immunisation reaction,Vaccination related complications,Procedural related injuries and complications NEC,Inj&P,N
2589,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2590,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2590,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2590,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2590,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2590,5,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2591,1,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2592,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2592,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2593,1,Sinus bradycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
2594,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2595,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2596,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2596,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2597,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2598,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2598,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2598,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2599,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2599,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2599,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2600,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2600,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2601,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2602,1,Parkinsonism,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
2603,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2604,1,Product use complaint,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2605,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2605,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2606,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2606,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2607,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2608,1,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2609,1,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2610,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
2611,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2612,1,Headache,Headaches NEC,Headaches,Nerv,N
2613,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2613,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2614,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2614,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2615,1,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2616,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2617,1,Cytogenetic abnormality,Chromosomal abnormalities NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
2617,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2617,3,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2617,4,Hyperbilirubinaemia neonatal,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
2617,5,Intraventricular haemorrhage neonatal,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2617,6,Neonatal respiratory distress syndrome,Neonatal hypoxic conditions,Neonatal respiratory disorders,Resp,N
2617,7,Neonatal seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2617,8,Periventricular leukomalacia,Encephalopathies NEC,Encephalopathies,Nerv,N
2617,9,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
2617,10,Pulmonary haemorrhage neonatal,Newborn respiratory disorders NEC,Neonatal respiratory disorders,Resp,N
2617,11,White matter lesion,Structural brain disorders NEC,Structural brain disorders,Nerv,N
2618,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2618,2,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
2618,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2618,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2618,5,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
2618,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2619,1,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
2620,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2620,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2620,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2620,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2621,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2622,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2622,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2622,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2622,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2622,5,Product after taste,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2623,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2623,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2624,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2625,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2626,1,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
2627,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2627,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2627,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2628,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2629,1,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
2630,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2630,2,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2631,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2632,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2632,2,Alcohol intolerance,Food malabsorption and intolerance syndromes (excl sugar intolerance),Food intolerance syndromes,Metab,N
2632,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2632,4,Dizziness postural,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2632,5,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2632,6,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2632,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2632,8,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
2632,9,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2633,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2634,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2634,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2635,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2636,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2637,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2637,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2637,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2638,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2638,2,Headache,Headaches NEC,Headaches,Nerv,N
2639,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2640,1,Epididymitis,Male reproductive tract infections,Infections - pathogen unspecified,Infec,N
2641,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2642,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2642,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2643,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2644,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2645,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
2646,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2647,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2647,2,Migraine,Migraine headaches,Headaches,Nerv,N
2647,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2647,4,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2648,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
2649,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2650,1,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2651,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2652,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2653,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2654,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2655,1,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
2656,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2657,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2658,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2659,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2660,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2661,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2661,2,Migraine,Migraine headaches,Headaches,Nerv,N
2661,3,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2662,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2662,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2663,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2664,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2665,1,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
2666,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2666,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2666,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2666,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
2666,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2667,1,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2668,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2669,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2670,1,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2671,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2672,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2672,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
2672,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2673,1,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2674,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
2675,1,Breath odour,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2675,2,Dental plaque,Dental surface disorders,Dental and gingival conditions,Gastr,N
2675,3,Oropharyngeal plaque,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2675,4,Tongue coated,Tongue signs and symptoms,Tongue conditions,Gastr,N
2676,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
2677,1,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2678,1,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2678,2,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2678,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2678,4,Supraventricular extrasystoles,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
2679,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2680,1,Dyschezia,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
2680,2,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2681,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2681,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2681,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2682,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2683,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2684,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2685,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2685,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2685,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2686,1,Lip dry,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
2686,2,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2687,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2688,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2689,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2690,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2691,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2692,1,Migraine,Migraine headaches,Headaches,Nerv,N
2693,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2694,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2695,1,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2696,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2697,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2697,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2697,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2697,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2697,5,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2698,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2699,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2700,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
2700,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2700,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2700,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2701,1,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2702,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2702,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2702,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2703,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
2704,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2705,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2705,2,Haemorrhoidal haemorrhage,Haemorrhoids and gastrointestinal varices (excl oesophageal),Gastrointestinal vascular conditions,Gastr,N
2706,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2706,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2706,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2706,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2706,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2707,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2708,1,Headache,Headaches NEC,Headaches,Nerv,N
2709,1,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2710,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2710,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
2710,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2710,4,Headache,Headaches NEC,Headaches,Nerv,N
2711,1,Faeces discoloured,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
2712,1,Post-acute COVID-19 syndrome,Coronavirus infections,Viral infectious disorders,Infec,N
2713,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2714,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2715,1,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2716,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2717,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2717,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
2718,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2719,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2719,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2719,3,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
2719,4,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2720,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2721,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2722,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2723,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2723,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2723,3,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2724,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2724,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2724,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2725,1,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2726,1,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2727,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2727,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
2727,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2728,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2728,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2728,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2729,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2730,1,Headache,Headaches NEC,Headaches,Nerv,N
2731,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2732,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
2732,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2732,3,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2732,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
2732,5,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2733,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2734,1,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2735,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2736,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2737,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2738,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2739,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2740,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2740,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2741,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2741,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2741,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2741,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2742,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2742,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2743,1,Headache,Headaches NEC,Headaches,Nerv,N
2744,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2745,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2746,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2747,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2747,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2748,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2749,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2750,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2751,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2751,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2751,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2751,4,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2751,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2752,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2753,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2754,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2755,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2756,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2757,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2758,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2759,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2759,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2759,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2760,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2761,1,Flank pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2762,1,Dry throat,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2762,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2763,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2764,1,Arthropod bite,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2764,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2765,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2766,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2767,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2767,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2767,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2768,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2769,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2770,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
2770,2,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
2771,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2772,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2773,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2774,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2774,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2775,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2776,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2777,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2778,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
2778,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
2778,3,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
2779,1,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2779,2,Tension,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2780,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2781,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2781,2,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2781,3,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2782,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2783,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2783,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2784,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2785,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2786,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2787,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2787,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
2788,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2789,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2789,2,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2790,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2791,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2792,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2792,2,Proctalgia,Anal and rectal pains,Anal and rectal conditions NEC,Gastr,N
2793,1,Headache,Headaches NEC,Headaches,Nerv,N
2794,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2795,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2796,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2797,1,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
2798,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2799,1,Post-acute COVID-19 syndrome,Coronavirus infections,Viral infectious disorders,Infec,N
2800,1,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
2801,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2801,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2802,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2802,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2802,3,Headache,Headaches NEC,Headaches,Nerv,N
2802,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2803,1,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2804,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2805,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2805,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2805,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2805,4,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2805,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2805,6,Headache,Headaches NEC,Headaches,Nerv,N
2805,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2805,8,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2805,9,Tension headache,Headaches NEC,Headaches,Nerv,N
2805,10,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2805,11,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2806,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2807,1,Headache,Headaches NEC,Headaches,Nerv,N
2808,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2808,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2808,3,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2809,1,Headache,Headaches NEC,Headaches,Nerv,N
2809,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2809,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2809,4,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2810,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2810,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2810,3,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2811,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2811,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2811,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2811,4,Headache,Headaches NEC,Headaches,Nerv,N
2811,5,Immobile,Disability issues,Lifestyle issues,SocCi,N
2811,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2811,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2811,8,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
2811,9,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
2812,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2813,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2814,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2815,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2816,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2817,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2817,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2817,3,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2818,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2819,1,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2820,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2821,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
2821,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
2821,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2822,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2823,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2824,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2824,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2825,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2825,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2825,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2826,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2827,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2828,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2829,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2830,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2831,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2832,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2832,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
2833,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2833,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2834,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2835,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2835,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2836,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2836,2,Headache,Headaches NEC,Headaches,Nerv,N
2837,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2838,1,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2839,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2840,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2841,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2842,1,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2843,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2843,2,Migraine,Migraine headaches,Headaches,Nerv,N
2844,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2844,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2844,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2845,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2846,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2847,1,Acute psychosis,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
2848,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2849,1,Conjunctivitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
2849,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2850,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2850,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2850,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2850,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2850,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2850,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2851,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2852,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2852,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2853,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2853,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2853,3,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2853,4,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2853,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2853,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2853,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2853,8,Headache,Headaches NEC,Headaches,Nerv,N
2853,9,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2853,10,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2854,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2855,1,Symptom recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2856,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2857,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2858,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2858,2,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
2858,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2858,4,Headache,Headaches NEC,Headaches,Nerv,N
2859,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2859,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2860,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2861,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2861,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
2862,1,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
2862,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2863,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2863,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2864,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
2865,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2865,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2866,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2866,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2867,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2867,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2868,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2868,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2868,3,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2869,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2870,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2870,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2870,3,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2871,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2872,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2873,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2873,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2874,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2875,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2876,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2877,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2877,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2877,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2878,1,CD4 lymphocytes increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2878,2,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2879,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2880,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2880,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2880,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2880,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2880,5,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2881,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2882,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2883,1,Headache,Headaches NEC,Headaches,Nerv,N
2884,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
2885,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2885,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2886,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2887,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2887,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2887,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2887,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2888,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2888,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2888,3,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
2888,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
2889,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2890,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2890,2,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
2891,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
2891,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2891,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
2892,1,Product taste abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2892,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2893,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2893,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2893,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2894,1,HIV viraemia,Retroviral infections,Viral infectious disorders,Infec,N
2894,2,Maternal exposure during breast feeding,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2894,3,Virologic failure,Infections NEC,Infections - pathogen unspecified,Infec,N
2895,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
2895,2,Mouth swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
2896,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2897,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2898,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2899,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2900,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2901,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
2901,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2902,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2902,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2902,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2902,4,Migraine,Migraine headaches,Headaches,Nerv,N
2902,5,Mucous stools,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
2902,6,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2902,7,Renal pain,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
2903,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2904,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2905,1,Oral mucosal erythema,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2906,1,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2907,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2908,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2908,2,Anosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
2909,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2910,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2911,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2911,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2912,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2913,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2913,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2914,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2915,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2915,2,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
2916,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2916,2,Capillary leak syndrome,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2916,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
2916,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
2917,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2917,2,Headache,Headaches NEC,Headaches,Nerv,N
2917,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2917,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2918,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2919,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2920,1,Body temperature abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2920,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2920,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2921,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2922,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2923,1,Heart rate,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2924,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2924,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2924,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2925,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2925,2,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2925,3,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2925,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2926,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2927,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2928,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2928,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2928,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2929,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2930,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2930,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2931,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2932,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2933,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2933,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2933,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2934,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2934,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2935,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2935,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2935,3,Glossodynia,Tongue signs and symptoms,Tongue conditions,Gastr,N
2935,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2935,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2935,6,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2936,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2936,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2936,3,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2937,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2937,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2938,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2939,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2939,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2940,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2940,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2940,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2940,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2941,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2941,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2941,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2942,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
2943,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2944,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2944,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2945,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2945,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
2946,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2947,1,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
2948,1,Suspected COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2949,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2949,2,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
2950,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2951,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2952,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2952,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2952,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2952,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2953,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2953,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2954,1,Change in seizure presentation,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2954,2,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2955,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
2955,2,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2956,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
2956,2,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2957,1,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
2957,2,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2957,3,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
2957,4,Viral mutation identified,Virus identification and serology,Microbiology and serology investigations,Inv,N
2958,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
2958,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
2958,3,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2959,1,Cerebellar ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2959,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2959,3,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2960,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2960,2,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2960,3,Parkinsonism,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
2960,4,Viral mutation identified,Virus identification and serology,Microbiology and serology investigations,Inv,N
2961,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2961,2,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2961,3,Parkinsonism,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
2961,4,Viral mutation identified,Virus identification and serology,Microbiology and serology investigations,Inv,N
2962,1,Cheilitis,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
2962,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2962,3,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
2962,4,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2962,5,Gingival disorder,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
2962,6,Gingival pain,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
2962,7,Headache,Headaches NEC,Headaches,Nerv,N
2962,8,Lip pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2962,9,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
2962,10,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2962,11,Oral mucosal erythema,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2962,12,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2962,13,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2962,14,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
2962,15,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
2962,16,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2962,17,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
2963,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2964,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2965,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2966,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2967,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2967,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2967,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2968,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2968,2,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
2968,3,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2969,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2970,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2971,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2972,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2973,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
2973,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2973,3,Headache,Headaches NEC,Headaches,Nerv,N
2974,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2975,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
2976,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2976,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2976,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2976,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2977,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2978,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2978,2,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2979,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2980,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2981,1,Headache,Headaches NEC,Headaches,Nerv,N
2982,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2983,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2983,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2983,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2984,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2985,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2985,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2986,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2986,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2986,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2987,1,Symptom recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2988,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2989,1,Symptom recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2990,1,Lip dry,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
2991,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2992,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2993,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2993,2,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2994,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2995,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2995,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2995,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2996,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2996,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2997,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2997,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2998,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2998,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2999,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
3000,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3001,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3002,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3002,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3002,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3002,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3003,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3004,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3004,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3004,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3005,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3005,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3006,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3007,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3007,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3007,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3007,4,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3008,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3009,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3010,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
3011,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3012,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3012,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3012,3,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3012,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3013,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3013,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3013,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3014,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3014,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3015,1,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3016,1,Headache,Headaches NEC,Headaches,Nerv,N
3017,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
3017,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
3017,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3017,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3018,1,Tongue discolouration,Tongue signs and symptoms,Tongue conditions,Gastr,N
3019,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3019,2,Headache,Headaches NEC,Headaches,Nerv,N
3019,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3019,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
3020,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
3021,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3022,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
3022,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3022,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3022,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3022,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3022,6,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3023,1,Autoimmune hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
3023,2,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
3024,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3024,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3024,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3024,4,Headache,Headaches NEC,Headaches,Nerv,N
3025,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3026,1,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
3026,2,Virologic failure,Infections NEC,Infections - pathogen unspecified,Infec,N
3027,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
3028,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3029,1,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
3030,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3031,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3032,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3032,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3032,3,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3033,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3033,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3034,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3034,2,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
3035,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3036,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3036,2,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3037,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3038,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3039,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3039,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3040,1,Lip ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
3041,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
3042,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3043,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3043,2,Delirium,Deliria,Deliria (incl confusion),Psych,N
3043,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3043,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3043,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3043,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
3043,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3044,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3045,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3046,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
3047,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3047,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
3047,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3048,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3049,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3049,2,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3050,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3051,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3052,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3053,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
3053,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3054,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3055,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3056,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3057,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3057,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3058,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3058,2,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3059,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3060,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3061,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3062,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3063,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3064,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3065,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3065,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3066,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3067,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3067,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
3068,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
3068,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3068,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3068,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3069,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3070,1,Abnormal faeces,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
3070,2,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
3071,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3071,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3071,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3072,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3072,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3072,3,Intracranial aneurysm,Central nervous system aneurysms and dissections,Central nervous system vascular disorders,Nerv,N
3072,4,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
3073,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3073,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3073,3,Intracranial aneurysm,Central nervous system aneurysms and dissections,Central nervous system vascular disorders,Nerv,N
3073,4,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
3074,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3074,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3075,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3075,2,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3075,3,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3076,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3077,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3077,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3077,3,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
3077,4,Headache,Headaches NEC,Headaches,Nerv,N
3078,1,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3079,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3080,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3080,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3081,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
3081,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3081,3,Headache,Headaches NEC,Headaches,Nerv,N
3081,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3082,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3082,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3082,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3083,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3084,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
3084,2,Headache,Headaches NEC,Headaches,Nerv,N
3084,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3084,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3084,5,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3084,6,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3084,7,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3085,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3086,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3087,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3088,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
3088,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3089,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3090,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3090,2,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
3090,3,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
3090,4,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3091,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3092,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3092,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3092,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3093,1,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3094,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
3094,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3095,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3096,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3096,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3097,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3097,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
3097,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3098,1,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
3099,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3099,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3100,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3101,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3101,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3101,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3102,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3103,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
3104,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3105,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3106,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3107,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
3108,1,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3108,2,Feeling jittery,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3108,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3109,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3109,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3110,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3111,1,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3112,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3113,1,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3114,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3115,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3116,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3117,1,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3118,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
3119,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
3119,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3120,1,Post-acute COVID-19 syndrome,Coronavirus infections,Viral infectious disorders,Infec,N
3121,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3122,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3123,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3124,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3125,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3126,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3127,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3128,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3129,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3129,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3130,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3131,1,Headache,Headaches NEC,Headaches,Nerv,N
3131,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3132,1,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
3133,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3134,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3134,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3135,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3135,2,Anosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
3135,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3136,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3137,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3138,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
3138,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3138,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3138,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3138,5,Headache,Headaches NEC,Headaches,Nerv,N
3138,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3139,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3139,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3139,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
3140,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3140,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3141,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3142,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3142,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3142,3,Gingival pain,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
3143,1,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
3144,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3145,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3145,2,Tongue discolouration,Tongue signs and symptoms,Tongue conditions,Gastr,N
3146,1,Oropharyngeal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3146,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3147,1,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3148,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3149,1,Bedridden,Disability issues,Lifestyle issues,SocCi,N
3149,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3149,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3149,4,Malnutrition,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
3149,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3149,6,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
3150,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
3151,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3152,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3153,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3153,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3154,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3155,1,Apparent death,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3155,2,Bedridden,Disability issues,Lifestyle issues,SocCi,N
3155,3,Bone disorder,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
3155,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3155,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3155,6,Malnutrition,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
3155,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3155,8,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
3155,9,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
3156,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3156,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3157,1,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
3158,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3159,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
3159,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3159,3,Negative thoughts,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
3159,4,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
3160,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
3160,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3161,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3162,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3162,2,Headache,Headaches NEC,Headaches,Nerv,N
3162,3,Parosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
3163,1,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
3164,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3165,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3166,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3166,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3167,1,Retroviral rebound syndrome,Retroviral infections,Viral infectious disorders,Infec,N
3168,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3168,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3169,1,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3170,1,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3171,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3171,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3171,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3172,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3172,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3173,1,Retroviral rebound syndrome,Retroviral infections,Viral infectious disorders,Infec,N
3174,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3174,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3175,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
3175,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3176,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3176,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3177,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3178,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
3178,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
3179,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3180,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3181,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3181,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3182,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3182,2,Anosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
3182,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3183,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3183,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3183,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3183,4,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3184,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3185,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3185,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3185,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3186,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3187,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3188,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3188,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
3189,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3189,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3189,3,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3190,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3191,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3192,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3193,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3194,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3195,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3195,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3196,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3196,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3196,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3197,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3197,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3198,1,Product after taste,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3199,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3200,1,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3201,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3201,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3202,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3202,2,Stillbirth,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
3203,1,Congenital central nervous system anomaly,Central nervous system disorders congenital NEC,Neurological disorders congenital,Cong,N
3203,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3203,3,Pulmonary hypoplasia,Pulmonary and bronchial disorders congenital,Respiratory disorders congenital,Cong,Y
3204,1,Acne,Acnes,Skin appendage conditions,Skin,N
3204,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
3204,3,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3204,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3204,5,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3205,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3205,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
3205,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3205,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3205,5,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
3206,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3206,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
3206,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
3207,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
3208,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3209,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3209,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3210,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3210,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3211,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3211,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
3211,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3212,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3212,2,Tongue discolouration,Tongue signs and symptoms,Tongue conditions,Gastr,N
3213,1,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3214,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3214,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3215,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
3216,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3217,1,Myopia,Refractive and accommodative disorders,Vision disorders,Eye,N
3218,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3219,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
3220,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3221,1,SARS-CoV-2 test,Virus identification and serology,Microbiology and serology investigations,Inv,N
3222,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3222,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3222,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3222,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3223,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3223,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3224,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
3225,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3225,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3226,1,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3226,2,SARS-CoV-2 test,Virus identification and serology,Microbiology and serology investigations,Inv,N
3227,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
3227,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3227,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3227,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3228,1,Headache,Headaches NEC,Headaches,Nerv,N
3229,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3229,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3230,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3230,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3231,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3232,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3232,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3233,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3233,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3234,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3234,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3235,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3236,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
3237,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
3237,2,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3237,3,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
3238,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
3239,1,Blood lactic acid,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
3239,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3240,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3241,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3241,2,Headache,Headaches NEC,Headaches,Nerv,N
3242,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3243,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3244,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3245,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
3246,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3246,2,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3246,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3246,4,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
3247,1,Headache,Headaches NEC,Headaches,Nerv,N
3248,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3248,2,Viral mutation identified,Virus identification and serology,Microbiology and serology investigations,Inv,N
3249,1,Viraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3250,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3250,2,Product after taste,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3251,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3251,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3251,3,Gastrointestinal stoma output abnormal,Gastrointestinal function diagnostic procedures,Gastrointestinal investigations,Inv,N
3251,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3251,5,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3252,1,Viraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3253,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3253,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3254,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
3254,2,Blood insulin abnormal,"Gastrointestinal, pancreatic and APUD hormone analyses",Endocrine investigations (incl sex hormones),Inv,N
3255,1,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
3256,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3257,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3258,1,Symptom recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3259,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3259,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
